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CHAPTER I 
 
MATRIX-ASSISTED LASER DESORPTION/IONIZATION IMAGING MASS 
SPECTROMETRY AND PROTEIN IDENTIFICATION 
This chapter was adapted from the previous published Ryan et al., Current Opinion in Chemical 
Biology, Copyright 2018 by Elsevier 
 
Overview 
 With the completion of the Human Genome Project, and the identification of some 30,000 
genes, understanding normal biological processes and disease pathogenesis has transitioned from 
studying changes in the genome to focus more on understanding the downstream effects by 
studying their protein products.1 Proteomic studies often aim to identify proteins and their various 
proteoforms that are directly involved or implicated in a disease, and identifying possible 
candidates for therapeutics.2 As the human proteome is quite complex, with upwards of an 
estimated 1,000,000 possible proteoforms in a given cell, this feat is not easily achieved.3 The field 
of proteomics has given rise to a number of new analytical technologies and advances that focus 
on collecting and deciphering as much proteomic information as possible from a single 
experiment. For example, bottom-up and top-down proteomics have revolutionized the way in 
which a protein is identified using mass spectrometry. Further, the coupling of mass spectrometry 
to multidimensional chromatography has enabled excellent proteomic coverage of a sample. 
Alongside MS approaches, nuclear magnetic resonance (NMR) has been applied extensively in 
structural proteomic studies. These developing techniques and technologies provide many means 
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to gather more reliable information than previously possible. However, the majority of these 
approaches sacrifice the spatial integrity of the sample and often focus on the analysis of proteins 
from cultured cells or tissue homogenates. 
The ability to identify proteins and map their spatial distributions in a tissue sample is a 
powerful way to track possible changes associated with a specific disease, and is a major goal of 
those using matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry 
(IMS). The analysis of proteins from a tissue sample using MALDI mass spectrometry give rise 
to a number of challenges ranging from analyte ionization and transmission, to identification. The 
work presented below looks to address and solve challenges associated with protein identification 
from tissue by implementing new instrumental modifications and developing new protein ID 
workflows. 
 
Introduction 
Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry 
Mass spectrometry (MS) is an analytical technology that allows for the direct measurement 
of the mass-to-charge (m/z) of an ion of a chemical species. To transmit and detect molecules in a 
mass spectrometer they must first undergo an ionization event that imparts a positive or negative 
charge on the molecules of interest. A number of ionization techniques have been developed over 
the past decades that have enabled the study of molecular classes ranging from small 
molecules/metabolites to larger, intact proteins.4 Originally developed in the late 1980s separately 
by Tanaka and Hillenkamp,5, 6 matrix-assisted laser desorption/ionization (MALDI) is a soft 
ionization technique that allows for the direct measurement of analytes from surfaces, and has been 
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applied to study most biomolecular classes.4, 7-9 In MALDI MS the analyte is first co-crystalized 
with a small molecule matrix, depicted in Figure 1.1. Once crystalized, a UV laser irradiates the 
matrix/analyte mixture. The matrix functions to absorb the UV radiation and desorb/ionize the 
analyte molecules. A number of particles are generated during the MALDI event, including 
neutrals, matrix ions, free electrons, free analyte ions, and matrix-bound analyte clusters. During 
the ionization event, the matrix molecule will donate, or abstract, a proton to the analyte molecule, 
creating an ion and thus measurable by a mass spectrometer. Historically, MALDI was 
accomplished using nitrogen lasers (λ: 337 nm). With the advancement of laser technology, the 
field has transitioned to primarily using solid state lasers. The most commonly employed lasers 
are frequency triple neodymium-doped yttrium (Nd:YAG, λ: 335 nm) and frequency tripled 
neodymium-doped yttrium lithium fluoride (Nd:YLF, λ: 349 nm). These lasers have much higher 
repetition rates and much longer lifespans than the previously used nitrogen lasers, and many 
matrices used for MALDI absorb efficiently at these wavelengths. For example, sinapinic acid 
(SA, 3,5-dimethoxy-4-hydroxycinnamic acid) is a suitable MALDI MS matrix that is used widely 
to analyze proteins and has an λmax at approximately 337 nm.10 Ions generated during the MALDI 
event are typically in low charge states (< 3) and undergo little fragmentation and thus the resulting 
mass spectra are simple to interpret.  
 
4 
 
 
Figure 1.1: Schematic depicting matrix-assisted laser desorption/ionization. A UV laser, depicted 
as a red arrow, is used to irradiate a co-crystalized mixture of analyte and matrix molecules which 
are represented as yellow and blue circles, respectively. The matrix molecules absorb the irradiated 
light and ions and neutrals are vaporized from the surface. Analytes are ionized via gas-phase 
protonation from the matrix molecules and are then transmitted and measured using mass 
spectrometry.  
 
 
 
MALDI Imaging Mass Spectrometry and MALDI Profiling of Proteins from Tissue 
MALDI imaging mass spectrometry (MALDI IMS) was introduced by Caprioli et al. in 
the late 1990s and has seen tremendous growth in utility and application, being employed to 
analyze biological substrates ranging from non-mammalian plants and insects to mammalian tissue 
specimens where it has had the broadest application.11-14 MALDI IMS is a unique molecular 
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imaging modality in that it allows for the label-free, multiplex analysis of thousands of analytes 
across a samples surface, yielding 2-dimensional molecular maps of the localization of both an 
analyte and its relative abundance at a given position. The technology has been used to study a 
wide range of analyte classes from tissue, including metabolites, lipids, peptides, glycans, and 
proteins.15-18 Protein analysis has garnered a lot of attention in the imaging community due to the 
fundamental biological role the proteome plays in the understanding of biology and disease 
progression.2 The typical MALDI IMS workflow for protein analysis from tissue is illustrated in 
Figure 1.2. First, the tissue is sectioned thinly, most commonly 10-20 µm, and thaw-mounted onto 
a conductive slide. Once mounted, a series of organic solvent washes is completed to remove 
excess salts and lipids. The slide and section are then homogenously coated with a MALDI matrix. 
As discussed earlier, MALDI matrices are generally small aromatic compounds that have an 
absorbance at the emitting MALDI laser wavelength, and often contain either a basic or acidic 
site.19 Matrix is most commonly applied via a robotic pneumatic sprayer system, or by sublimation 
onto the tissue surface. Once coated, the sprayed slide can be recrystallized to better extract 
proteins into the matrix layer.20 The sample is then loaded into the instrument and a raster of the 
laser is performed across the tissue surface, moving a defined lateral distance, and generating a 
mass spectrum at each location. Ion intensities for a selected mass range are then plotted in a 
coordinate system that matches the image acquisition, creating an ion image. A number of reviews 
highlight the merits, outlooks, and applications of MALDI imaging mass spectrometry.21, 22 
Aside from MALDI IMS acquisitions from entire sections of tissue, MALDI profiling 
experiments can also be completed in order to generate proteomic profiles from discrete regions 
of tissue. This type of workflow is often utilized when looking to compare various regions of 
tissue, or to categorize certain disease types according to their unique MALDI profiles.23 Here, the 
6 
 
tissue preparation is completed as discussed earlier, but instead of a laser raster across the entire 
section, individual mass spectra are collected at distinct locations (Figure 1.3).24 This type of 
approach allows for a histology-directed profiling of tissue features and has been applied to study 
molecular classes ranging from small molecules metabolites and lipids, but is most commonly 
applied to study proteins as it allows for the direct m/z measurement of a protein and its various 
proteoforms from tissue.23, 25, 26   
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Figure 1.2: Overview of a protein MALDI IMS acquisition from a section of mouse pup. A) 
Tissue is sectioned and mounted onto a conductive slide. Lipids and interfering salts are washed 
away and matrix is applied homogenously to the surface.  B) Mass spectra are acquired at each x 
and y-coordinate. C) Ion images are generated by plotting the intensity of individual protein ions 
across the tissue section. D) Following, or in parallel to IMS experiments, orthogonal 
experiments are completed in order to generate protein identifications that can be correlated to 
the imaging data. Figure is adapted from citation.27  
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Figure 1.3: Visual depiction of a MALDI profiling experiment where a mass spectrum is 
generated from a specific region of interest (ROI) on the tissue. 
 
Time of Flight Mass Spectrometry 
 Historically, protein IMS has been carried out on time-of-flight (TOF) instruments due to 
their sensitivity, increased mass range (routinely up to 30,000 m/z for MALDI IMS), relatively 
low cost, and high acquisition speed.28 TOF mass spectrometers have been coupled to a number 
of ionization sources, such as DESI and SIMS, but MALDI is still the most commonly used ion 
source for tissue analysis.29, 30 Mass analysis on a TOF is completed by first accelerating ions to 
equal kinetic energies, and focusing their trajectories through a field-free flight tube. This initial 
kinetic energy is defined in Equation 1.1 and is the product of the charge of the ion (z) and the 
accelerating voltage (V) 
Eq. 1.1  KE = zV 
Substitution of KE with the traditional equation for kinetic energy is presented in Equation 1.2, 
where (m) is the mass of the ion and (v) is the velocity 
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Eq. 1.2  KE = zV = mv
2
2
 
While traversing a known distance (i.e. the distance of the flight tube), ions will separate based on 
m/z, with the heavier ions requiring more time to travel the distance of the flight tube (Figure 1.4). 
The time neccessary to traverse this distance is measured and the m/z of the ion is calculated 
through instrument calibration. Substituting velocity for distance (d) and time (t) allows the 
rearrangement of the equation to measure the time-of-flight and discern the m/z of the ions 
(detailed below in Equation 1.3). 
Eq. 1.3  t = d� m
2zV
 
Advancements in TOF technology, such as delayed extraction31 and reflectron time-of-
flight MS32, has led to the increased use of TOF MS in a number of areas of mass spectrometry, 
and has allowed for its use in MALDI IMS to effectively analyze most biomolecular classes.33-35  
The advent of hybrid instruments, such as the quadrupole time-of-flight (Q-TOF) mass 
spectrometer has allowed for an increase in resolving power, and the ability to filter ions based on 
m/z, without sacrificing speed and sensitivity, and has been utilized for MALDI imaging of 
proteins.36, 37 Ion mobility coupled with TOF mass spectrometry is also being leveraged in protein 
imaging studies, as a new means of completing gas-phase separations prior to mass analysis.38 
Although TOF mass spectrometers are robust, relatively affordable, and are a common choice for 
IMS acquisitions, they suffer from limited mass accuracy and mass resolving power, particularly 
when operated in linear mode for the analysis of higher m/z species (i.e. > 3000 Da). These two 
drawbacks are problematic for identifying proteins: there is diminished accurate mass and poor 
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mass resolution to determine other qualities like protein charge state or modification. As a result 
of this, other higher resolving power platforms have started to be used in use in MALDI IMS. 
 
 
Figure 1.4: A schematic depicting a MALDI linear time-of-flight mass spectrometer. Three ions 
of varying mass, represented by the colored circles, are accelerated to same initial kinetic energy 
after being ionized by a laser. Ions are then accelerated down a field-free drift tube where they 
separate by m/z. 
 
 
Fourier Transform Ion Cyclotron Resonance Mass Spectrometry 
Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometers have played a 
critical role in the analysis of complex mixtures, such as the environment encountered in tissue. 
FT-ICRs have unsurpassed resolving power and mass accuracy, allowing for the separation of 
isotopes present in high m/z species like intact proteins. An in-depth review of FT-ICR theory is 
outside the goals of this dissertation and can be found elsewhere;39 however, a concise explanation 
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on how they function in MALDI analysis is worthwhile. Briefly, ions are generated using the 
MALDI process and transmitted via ion optics to an ICR cell located within a super conducting 
magnet (normally 7-15T in strength). In the presence of a homogenous magnetic field, the ion 
population will begin to undergo a rotational motion due to a Lorentz force (Equation 1.4) acting 
upon them, and the ions will begin to bend in a circular path. In Eq. 1, (m) is the mass of the ion, 
(q) is the charge, and (v) is the velocity of the ion, (B) is the magnetic field strength, and (t) is time 
Eq. 1.4  Force = m · acceleration = mdv
dt
 = qv x B 
Should the ions remain at a constant speed and undergo no collisions, their path will bend into a 
circle with a radius (r) determined by the strength of the magnetic field. The frequency of this 
rotation (i.e. their cyclotron frequency) is m/z dependent, with heavier ions of the same charge 
rotating at lower frequencies. Equation 1.5 denotes the “unperturbed” cyclotron frequency, where 
(vc) represents the cyclotron frequency, (ωc) is angular velocity, (m/z) is the mass-to-charge ratio 
of the ion, and (B) is the field strength 
Eq. 1.5  vc = ωc
2π
 = 1.535611 x 10
7B
m/z
  
The ions are confined radially to the ICR cell by the magnetic field, and axially by trapping 
electrodes. As the ions are confined to the center of the cell, and spinning in a rotational motion, 
resonant excitation is used to excite all ions to a larger diameter, inducing coherency among the 
ion populations and pushing them close to electrodes where an image current is induced (Figure 
1.5). The frequency of all ions is measured simultaneously for a defined period of time (usually < 
2 seconds) captured in a time-domain signal, and a Fourier transform is used to generate a 
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frequency spectrum. The measured frequencies are then converted to a mass spectrum (Figure 1.6) 
through calibration. Recently, FT-ICRs have begun to play a significant role in protein imaging 
and have been applied to study various biological applications.40 However, the increased power of 
these platforms does come with drawbacks for MALDI IMS; namely, FT-ICRs require longer scan 
times for analysis. For comparison, high-speed TOF platforms can image upwards of 50 pixels a 
second, while an FT-ICR may only be capable of 0.1-3 pixels per second, creating long acquisition 
times, especially for higher spatial resolution or high mass resolving power imaging acquisitions. 
Due to these time constraints, some research labs have begun to leverage the high power afforded 
by an FT-ICR to help aid in protein identifications in tandem with the faster performing TOF 
platforms.41  
 
Figure 1.5: Spatial coherency is generated by applying an excitation waveform onto the electrodes 
of the ICR cell. Ions initially spinning in incoherent ICR motion become coherent, and expand to 
move closer to a pair of detection electrodes. An image current is induced upon these electrodes 
and ICR frequencies are measured. Adapted from citation.39 
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Figure 1.6: A schematic representing mass analysis using a Fourier transform ion cyclotron 
resonance mass spectrometer. Ions are generated, represented with colored circles, and transmitted 
to an ICR cell and begin to undergo a cyclotron motion in the presence of a large, homogenous 
magnetic field. Ions are excited to a larger radius by applying an excitation waveform. As the 
excited packets of ions move closer to detection electrodes, and image current is induced upon the 
electrodes and the frequencies of the ions are measured and captured in a time-domain signal. This 
signal undergoes a Fourier transform to a frequency-domain spectrum which is then translated into 
a mass spectrum.  
 
 
 
 
Protein Identification in MALDI IMS 
Protein identification in MALDI MS is crucial in helping to understand the physiological 
role of biomolecular and cellular systems. However, identifying proteins observed in many 
MALDI imaging and profiling experiments can be challenging because MALDI generated ions 
typically have low charge states (< 3), greatly reducing the gas-phase fragmentation efficiency and 
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ultimately resulting in limited sequence coverage.42, 43 In general, protein identification in mass 
spectrometry is performed using either bottom-up or top-down sequencing.44 Bottom-up protein 
identification methods rely on enzymatic digestion to hydrolyze larger proteins into smaller 
peptides that are easier to fragment, resulting in higher sequence coverage.45 In top-down methods, 
intact proteins are injected into the mass spectrometer and subjected to fragmentation without prior 
digestion.46 Aside from better tracking of protein modifications, an advantage of top-down protein 
sequencing is that it complements imaging experiments by enabling mass measurement of the 
intact protein that relates more directly to the MALDI IMS generated signals of intact proteins. 
For both bottom-up and top-down proteomics experiments, proteins and peptides are 
commonly fragmented using collision induced dissociation (CID) or electron transfer dissociation 
(ETD). In CID, ions are accelerated and collide with a neutral gas leading to increased internal 
energy of the ion. Should the deposited energy exceed the critical energy of a bond, fragmentation 
will occur.47 The ‘mobile proton model’ is used to describe the dissociation of proteins and 
peptides in CID studies.48 This model postulates that sequence fragments of highly charged 
proteins result from charge directed fragmentation after the mobilization of a proton to a carbonyl 
on the peptide backbone. However, MALDI primarily produces low charge state ions with few 
protons which tend to be sequestered on highly basic amino acid side chains (e.g. lysine and 
arginine). Thus, MALDI generated protein ions produce fragments with poor sequence coverage. 
In ETD, ions are bombarded with radical anions in an ion trap resulting in electron transfer and 
formation of radical cations. Once the radical cation is formed, rapid dissociation along the peptide 
backbone occurs resulting in informative sequence fragments.49 ETD requires that multiple 
protons are present, and the fragmentation efficiency for a given protein or peptide is highly 
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correlated to an increased charge state. For these reasons, the applicability of ETD to MALDI 
generated proteins is also limited. Figure 1.7 depicts these two fragmentation techniques.  
 
Figure 1.7: A cartoon schematic depicting the two common fragmentation techniques used in 
tandem mass spectrometry. A) CID relies on increasing the kinetic energy of the ion of interesting 
and colliding into a neutral background gas molecule. Upon collision, kinetic energy is converted 
to internal energy and should the deposition be large enough, the ion will fragment. B) Electron 
transfer dissociation occurs via radical-induced dissociation after the capture of an electron. In 
ETD this exchange occurs via a charge-transfer reaction involving a molecule with a low electron 
affinity.  
 
To overcome the challenges associated with identification of MALDI generated proteins, 
technologies and methods have been developed to enable separate, complimentary proteomics 
experiments to be performed as part of IMS workflows. These orthogonal experiments are 
typically performed on the sample following MALDI image analysis or using a serial tissue 
section. In general, these experiments involve the extraction of proteins from the tissue with 
subsequent analysis of the sample by electrospray ionization (ESI). ESI generally produces highly 
charged ions that are more amenable to CID and ETD fragmentation.50 By completing these 
experiments offline, protein identifications can be made using more traditional proteomics 
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workflows and the resulting identifications can be correlated to the imaging data through accurate 
mass matching.16, 51, 52  
Protein Identification Strategies 
Analytical methods for generating protein identifications in MALDI IMS and MALDI 
profiling workflows must balance trade-offs between the effective spatial resolution and sensitivity 
with respect to the number of proteins identified. The goal is to provide complimentary data by 
mapping protein identifications to distinct tissue substructures or cell types in the sample. Each 
approach has its own unique performance characteristics including spatial resolution, throughput, 
intact protein/peptide compatibility, and fragmentation method compatibility and is presented in 
Figure 1.8. 
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Figure 1.8: A schematic representing the 6 common approaches to gathering proteomic data from 
a tissue sample. 
 
Tissue Homogenization 
Many common approaches for extracting and identifying proteins from tissue utilize bulk 
tissue homogenization.50, 51 A number of protocols have been developed to enhance the detection 
of specific types of proteins (e.g. membrane and phosphorylated proteins),53, 54 as well as 
quantitative workflows.55 In general, the sample to be homogenized can be the remainder of tissue, 
a serial tissue section, or a punch biopsy if attempting to isolate analytes from discrete areas of 
tissue (> 250 µm). The sample is pulverized and undergoes a cell lysis step. Cell lysis is typically 
performed mechanically,56 and is followed by various solvent washes to solubilize and extract the 
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endogenous proteins. Proteins are either analyzed directly (top-down analysis) or undergo 
enzymatic digestion prior to MS analysis (bottom-up). Purification procedures are typically 
employed to increase sensitivity (i.e. removing salts, detergents, etc.). In both bottom-up and top-
down workflows the complex protein mixture is fractionated by gel electrophoresis or liquid 
chromatography. There are many examples of researchers employing this strategy in protein IMS 
workflows. For example, investigators have extracted and combined proteins from serial sections 
of rat brain tissue that were subsequently analyzed using top-down MS in order to link 
identifications to a MALDI FT-ICR IMS data set using mass accuracy.40 Although tissue 
homogenization is the most utilized strategy for tissue proteomics workflows, spatial fidelity is 
lost in most cases, limiting its application for the analysis of discrete foci in tissue.  
In Situ Enzymatic Digestion 
Ideally, proteins should be identified in an MALDI experiment workflow from their native 
environment; that is, directly from tissue. This allows both mass accuracy and spatial information 
to be used to relate imaging data to protein identification experiments. As described above, 
MALDI generated proteins suffer from inefficient fragmentation in the gas phase. To overcome 
this challenge, on-tissue enzymatic digestions can be performed to generate peptides from larger 
proteins that are more amenable to MS/MS experiments directly from tissue. Approaches utilizing 
in-situ enzymatic digestions are often performed using robotic sprayers to apply a homogenous 
coating of enzyme across the tissue section or by robotically depositing small (> ~200 µm), 
discrete droplets of enzyme on the surface.57, 58 An incubation step is performed prior to MALDI 
MS analysis. Trypsin is the most commonly employed enzyme, however, other endoproteinases 
such as Glu-C and Asp-N have been utilized for IMS studies.59, 60 Once digested, proteins can be 
identified by spatially targeting and sequencing peptides using traditional MS/MS approaches 
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directly from tissue. In an early example where trypsin was applied to lung tumor tissue micro-
arrays using an automated spotter, researchers were able to differentiate specific cancer types (e.g. 
adenocarcinoma from squamous cell carcinoma biopsies) by peptide imaging.61 In another 
approach, investigators combined MALDI IMS with ion mobility mass spectrometry and in-situ 
digestions from both fresh frozen and formalin fixed paraffin embedded tissue samples.62 The use 
of ion mobility provided separation of isobaric species that would not normally be observed using 
conventional MALDI IMS, enabling higher peak capacity in the tissue-based bottom-up 
proteomics analysis. Although effective for identifying proteins, there is currently no software 
available to allow for automated peptide fragmentation from tissue, limiting throughput and data 
interpretation.  
Chemical Derivatization 
Chemical derivatization entails modification of analytes present on the surface of the tissue 
to enhance analytical characteristics such as sensitivity and fragmentation efficiency.63 The 
majority of this work has been applied to the study of small molecule analytes to enhance 
sensitivity of species with low ionization efficiency.  However, there are a number of studies that 
have used chemical derivatization of proteins to simplify the resulting fragmentation data 
generated from bottom-up MALDI data sets.64, 65 Protein IMS workflows have been developed 
that include N-terminal derivatization strategies that yields only y-type sequence ions during 
MALDI TOF/TOF experiments.66 In this work a negative charge was added to the N-terminus of 
tryptic peptides using 3-sulfobenzoic acid succinimidyl ester (3-SBASE). This sulfonation agent 
was used to generate complete peptide y-fragment series from MALDI generated ions. Also, a 
sialic acid derivatization approach was developed for N-Glycan MALDI IMS from formalin fixed, 
paraffin-embedded tissues. In order to preserve the sialic acid group, which is often lost by in-
20 
 
source decay during ionization and ion transfer, they utilized a linkage-specific demethylation and 
amidation for stabilization.67 Similar to in-situ enzymatic digestion, these methods allow for the 
identification of proteins directly from tissue, but are throughput-limited and are better suited for 
targeted studies. 
Laser Capture Microdissection 
Laser capture microdissection (LCM) facilitates the interrogation of tissue foci and is well 
suited for cellular analysis, having the capability to sample single cells from heterogeneous 
environments using microscopy combined with a laser targeting system. In LCM, a laser is used 
to perforate the tissue and effectively cut out the target region, separating it from adjacent tissue. 
The separated tissue is then collected using a non-contact approach such as laser induced forward 
transfer (LIFT). LCM instrumentation commonly rely on ultraviolet (UV) and/or infrared (IR) 
lasers for tissue perforation and collection. Once collected, the tissue sample can be subjected to 
homogenization protocols and bottom-up or top-down workflows. In recent studies, high resolving 
power  FT-ICR MS with spatially targeted LCM was used to aid in identifying proteins from an 
IMS data set.16 These two platforms were employed to study and identify proteins in a mouse 
model of glioblastoma and enabled proteins to be identified specifically from tumor and non-tumor 
regions of tissue. New workflows integrating LCM and MALDI IMS have been reported using a 
parafilm-assisted microdissection (PAM).68 This approach enabled rapid and inexpensive LCM-
based proteomic analyses in IMS workflows. LCM allows for spatially targeted proteomic 
information to be gathered for specific cell types in tissue, but can suffer from poor sensitivity due 
to tissue loss, and requires long collection times. 
Hydrogel Extraction 
21 
 
Hydrogels are a superabsorbent polymer that are characterized by the ability to retain a 
large amount of liquid relative to volume and are inexpensive to fabricate. Hydrogels have found 
use in a diverse range of applications including microfluidics,69 wound care and drug delivery,70, 
71 and protein extractions.72, 73 Briefly, a hydrogel is cast into sheets through polymerization of 
water soluble monomeric units such as acrylamide. After casting, a punch biopsy is used to retrieve 
a gel of a specific diameter. The hydrogel can then be dehydrated and subsequently rehydrated 
with an enzyme solution, most commonly trypsin. The gel is then placed onto the surface of the 
tissue, leading to spatially targeted protein digestion and peptide extraction into the gel.  Peptides 
are then washed from the gel and analyzed by LC-MS. Hydrogels were initially investigated with 
applications to IMS as a cost-effective approach to generate spatially targeted protein 
identifications from tissue.72  This approach utilized laser printed molds creating an ionotropic 
hydrogel that were employed to extract and digest proteins from the cerebellum of a rat brain. 
Hydrogel fabrication was further optimized for tissue analysis using a polyacrylamide hydrogel 
and were able to fabricate the gels down to a diameter of 260 μm while still identifying hundreds 
of proteins species from tissue.74 Although efficient at generating spatially targeted protein 
identifications, hydrogels are limited in throughput due to the lengthy preparation and incubation 
time required for peptide extraction, as well as difficulties when attempting to manipulate a small 
gel on a tissue surface. 
Liquid Extraction Surface Analysis 
Liquid micro-extractions, commonly referred to as a liquid extraction surface analysis 
(LESA), utilize a small volume (~0.5-3 µL) of extraction solvent that can be placed on the samples 
surface. Analytes present in the tissue diffuse into the solvent that is subsequently aspirated off the 
tissue and analyzed by traditional proteomic workflows. A cartoon schematic depicting a protein 
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LESA from tissue is presented in Figure 1.9. Analyte classes ranging from small molecule 
metabolites to intact proteins have been studied using LESA technology. One of the more desirable 
characteristics of the experiment is the low cost associated with an experiment. Schey et al. 
generated liquid micro-extracts using a hand pipette and a gel loading pipette tip. Using this 
approach, they detected upwards of 100 intact protein species from thin tissue sections by simply 
dispensing 1-2 µL of extraction solvent onto a tissue using a gel loading pipette tip, aspirating the 
solvent, and taking it offline for top-down LC-MS/MS.75 New research has focused on making the  
Figure 1.9:  A schematic representing the LESA experiment extracting proteins from tissue. 
Extractions solvent is aspirated and dispensed onto a tissue’s surface where proteins diffuse into 
the solvent. The solvent is aspirated back from the tissue and can be injected directly into the mass 
spectrometer or taken offline and subjected to traditional bottom-up and top-down mass 
spectrometry approaches. 
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experiment more automated incorporating a robotically controlled extraction. Much of this work 
stems from initial research by Jack Henion and Gary Van Burkel.76, 77 A challenge to the LESA 
experiment is the size of the droplet diameter on tissue. Typically, LESA is limited to a spatial 
resolution of ~500 µm for routine use. Although limited in resolution, LESA provides a high-
throughput approach to gather spatially targeted protein identifications from tissue. 
Research Summary and Objectives 
 In order to improve our current approaches to spatially targeted proteomic studies from 
tissue, both instrumental modifications and new methodologies were implemented. First, 
modifications were made to a commercial 15T FT-ICR MS to improve protein ion transmission 
for higher m/z species. The source region of the instrument was modified to include a second rough 
pump as well as new isolation valves that allowed the source pressure to be adjusted. Optimizing 
the pressure allowed for ions up to m/z 24,000 to be transmitted, effectively doubling our 
analyzable mass range. Protein identification from tissue was improved by the optimization and 
implementation of a new robotic, liquid extraction surface analysis workflow. Online HPLC and 
offline proteomic strategies were developed to identify proteins that can be mapped back to the 
IMS data through accurate mass matching. The LESA resolution was improved by the addition of 
a spatially targeted, micro-enzymatic digestion, yielding a new workflow termed microLESA. This 
new approach incorporates both liquid micro-spotting and fluorescent microscopy to identify 
tissue foci and increase the resolution of analysis for a bottom-up LESA experiment. Following 
optimization and characterization, the new microLESA workflow was applied to study the host-
pathogen interface in a Staphylococcus aureus infection in murine kidney. The development of 
these new technologies are of great importance to the imaging community, allowing for a greater 
visualization of the proteome, and thus a better understanding of pathology and biology. The 
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utilization of these new technologies enable a superior approach to proteomic studies than were 
previously possible.   
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CHAPTER II 
 
IMPROVING PROTEIN ION TRANSMISSION ON A 15T FT-ICR MS FOR MALDI 
IMS 
This chapter was adapted from the previous published Prentice, Ryan et al., Analytical 
Chemistry, Copyright 2018 by ACS78  
 
Overview 
The molecular identification of proteins of interest is an important part of an imaging mass 
spectrometry (IMS) experiment. The high resolution accurate mass capabilities of FT-ICR MS 
have been shown to facilitate the identification of proteins in MALDI IMS. However, these 
experiments are typically limited to proteins giving rise to ions of relatively low m/z due to 
difficulties transmitting and measuring large molecular weight ions of low charge states. 
Modifications to the source region of a commercial MALDI FT-ICR MS to regulate gas flow and 
pressure enables the transmission and detection of protein species up to m/z 24,000 and the 
detection of proteins from tissue up to m/z 22,000. 
 
Introduction 
The ability to efficiently sample ions generated from relatively high pressure ion sources 
into the instrument vacuum chamber for analysis is a key factor in determining the overall 
sensitivity of a mass spectrometry experiment.  The advent of ambient ionization methods such as 
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electrospray ionization (ESI) has necessitated the development of improved methods of ion 
transmission across differentially pumped regions of the mass spectrometer.76, 79-85 The 
introduction of the ion funnel, which consists of a stack of closely spaced ring electrodes with 
successively decreasing inner diameters, has enabled ion transmission efficiencies that approach 
100%.86-88 Ion funnel interfaces are now present on many commercial mass spectrometers and can 
transmit ions with little m/z bias.89-91 While extensive studies have been performed to characterize 
the fundamental mechanisms of ion transmission and focusing in ion funnels for ESI-generated 
ions,92-96 relatively little work has been done to characterize the transmission efficiency of species 
generated by matrix-assisted laser desorption/ionization (MALDI), which can introduce unique 
considerations for ions of high m/z ratios. 
 The efficiency of ion transport through the funnel is governed by several processes, 
including the collection of ions emanating from the source and the collisional focusing of these 
species in the ion funnel. Important to both of these processes are the gas flow dynamics and the 
operating pressure of the system.87, 93 Off-axis gas flow can detrimentally effect the collection of 
ions into the mass spectrometer, and the operating pressure of the ion funnel (along with its 
physical dimensions and operating RF voltages) determines the effective electric field for ion 
confinement.92, 93 At increased operating pressures, the effective potential well for ions is 
suppressed and a decrease in ion radial confinement is observed.97 This situation is especially 
pronounced for ions of high m/z values (greater than 10,000) that have shallower pseudopotential 
well depths.96, 98, 99 Most ESI-based experiments analyze ions in a more modest mass range from 
m/z 200 to 3,000, such as analyses of singly charged metabolites and lipids and multiply charged 
peptides and proteins. Especially for high m/z species generated by ESI (e.g., intact protein 
complexes), additional processes such as ion desolvation become important to consider when 
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determining the operating parameters of the source.92, 100-102 Even these high molecular weight 
complexes are typically multiply charged and thus of relatively modest m/z value, perhaps 
explaining the scarcity of reports detailing the use of ion funnels to study ions in excess of m/z 
~10,000.103-105 In contrast to ESI, MALDI-generated protein ions are typically observed at low 
charge states (i.e., higher m/z) and do not undergo desolvation, although declustering during 
MALDI plume evolution could be an analogous process in this context.106-108 
 Recently, we have reported the detection of protein ions in an imaging mass spectrometry 
(IMS) experiment up to m/z ~12,000 with good signal-to-noise ratios (S/N), and up to m/z 17,000 
with low S/N, using a commercial ion funnel-based MALDI source on a Fourier transform ion 
cyclotron resonance (FT-ICR) mass spectrometer.109 While FT-ICR instruments have been widely 
used to study a variety of low molecular weight MALDI-generated ions,110-114 intact protein 
analysis by MALDI has historically been performed on time-of-flight (TOF) mass spectrometers 
due to the superior sensitivity of these platforms at high m/z ratios.115, 116 Most MALDI TOF 
instruments generally operate at high vacuum, making them incompatible with current ion funnel 
designs that typically operate at pressures of 0.1-30 Torr (~0.1-40 mbar). Despite the superior 
sensitivity of TOF-based platforms, the high mass resolving power and mass accuracy afforded by 
FT-ICR instruments have recently been demonstrated to facilitate the identification of isotopically-
resolved, MALDI-generated intact proteins in a complex mixture of species detected during a 
tissue imaging experiment.16, 109, 117 Early work by several groups noted the benefits of FT-ICR to 
studying high m/z ions generated using internal MALDI sources (i.e., located in the ultra-high 
vacuum region of the ICR cell).118-120 Although relatively little research has focused on high m/z 
species generated by external MALDI sources due to inefficient ion transmission, advances in ion 
optics and the use of stronger magnetic fields are now enabling these types of experiments.  
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 Herein, we have modified the source region of a 15T FT-ICR mass spectrometer in order 
to maximize the ion funnel transmission efficiency of high m/z MALDI-generated protein ions. 
The dual ESI/MALDI ion source on this instrument was modified to allow for control of the 
existing gas flow and pressure, both of which were identified to be important to ion transmission. 
Significant improvements in ion transmission efficiency were observed for protein standards up to 
m/z ~24,000 and for proteins detected from tissue up to m/z 22,000, roughly doubling the normal 
mass range and dramatically enhancing the quality of the protein imaging data. 
 
Results 
Systematic Study of Source Pressure 
 In order to maximize the transmission efficiency of MALDI-generated protein ions, we 
sought to optimize both the operating pressure of the ion funnel as well as effects of off-axis gas 
flow from the ESI capillary. In an effort to minimize the effects of the off-axis gas flow, the ESI 
source was raised to its maximum adjustable position, reducing the overlap with the MALDI ion 
generation region (Figure 2.2). MALDI mass spectra of a mixture of protein standards were then 
acquired as a function of source pressure, which was controlled by adjusting the valve attached to 
the ESI capillary (V3). In this configuration, both the V1 and V2 isolation valves are fully open. 
In general, the abundance of most protein ions increased as the source pressure was decreased from 
the normal operating pressure of ~2.9 Torr (~3.9 mbar) to ~800 mTorr (~1.1 mbar) (Figure 2.3). 
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Figure 2.1: Schematic of selected components in the instrument source region (not to scale) 
showing a) the normal gas manifold and b) the gas manifold that has been modified to incorporate 
isolation valves (V1 and V2), an additional source rough pump (RP2), a Pirani gauge (PG), and a 
valve to regulate gas flow through the ESI capillary (V3). 
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Figure 2.2: Vertical position of the ESI source in relation to the ion funnel to a) maximize or b) 
minimize overlap with the MALDI ion generation region, which occurs roughly in the center of 
the ion funnel. 
 
This effect is especially pronounced for the high m/z protein species, namely singly charged 
ubiquitin (Figure 2.3b), apomyoglobin (Figure 2.3c), and trypsinogen cations (Figure 2.3d). This 
increase in ion transmission efficiency at lower pressures is consistent with a greater effective 
potential wall confining the radial motions of the ions within the funnel.92, 93 Changes in axial gas 
flow dynamics and the axial DC gradient as they relate to the observed increases in ion 
transmission efficiency are thought to be minor under these operating conditions.92, 93, 96, 121 The 
most efficient ion transmission for the largest m/z species (singly charged apomyoglobin and singly 
charged trypsinogen) occurs between 700 and 800 mTorr. The abundance of these ions, as well as 
[trypsinogen + 2H]2+, is improved by at least an order of magnitude compared to that at the normal 
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source operating pressure (Figure 2.4). The signal-to-noise (S/N) improvement is especially 
dramatic for singly charged apomyoglobin and singly charged trypsinogen ions not observed at 
normal source pressure, but now readily detected. 
The signal intensity of the lower m/z species, namely [ubiquitin + 2H]2+, [apomyoglobin + 
2H]2+, and [trypsinogen + 3H]3+, is relatively unchanged as the pressure is decreased from 2.9 to 
1.0 Torr. However, the transmission efficiency of the multiply charged ions noticeably decreases 
as the pressure is reduced further below 1.0 Torr. This difference in transmission between singly 
and multiply charged species is consistent with the effective potential being higher for multiply 
charged ions.92, 97 The effective potential in vacuum at point (r, x) in cylindrical coordinates has 
been defined as: 
Eq. 2.1  V∗(r, x)  = q2ERF2 (r,x)
4mω2
~ z2VRF2
f2
      
where q = ze is the charge of the ion, ERF(r,x) is the local RF amplitude and is proportional to the 
RF voltage applied to the funnel (VRF), m is the  mass of the ion, ω = 2πf is the angular frequency, 
and z is the charge of the ion.93, 97 According to Equation 2.1, the effective potential is proportional 
to the square of the ion charge state, which supports the charge-state dependent curves in Figure 
2.3. As the effective potential increases, a low-mass cutoff effect (LMCO), analogous to that 
observed in RF multipole devices, appears to affect the stability of the lower m/z protein species. 
While the formation of multiply charged protein ions by MALDI has been shown by several groups 
to be more favorable at higher pressures,107, 122-126 a pressure-dependent shift in the charge state 
distribution of ions produced during the MALDI process seems unlikely here given that there is 
no concomitant decrease in abundance of the multiply charged species while the higher m/z singly 
charged species increase in abundance as the pressure is decreased from 2.9 to 1.0 Torr. 
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Figure 2.3: (a) Protein abundance as a function of source pressure for (b) ubiquitin, (c) 
apomyoglobin, and (d) trypsinogen. In c-d, the error bars represent the standard deviation of 3 
replicates. The source pressure was varied by adjusting gas flow through the ESI capillary (V3) 
and the ESI source is positioned to minimize the overlap with the MALDI ion generation region. 
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Figure 2.4: Representative protein standard mass spectra acquired at source pressures of a) 2.9 
Torr and b) 800 mTorr. The source pressure was varied by adjusting gas flow through the ESI 
capillary (V3) and the ESI source is positioned to minimize the overlap with the MALDI ion 
generation region. 
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When the ESI source is lowered to maximize the overlap with the MALDI ion generation 
region, the abundance of most protein species again increases as the source pressure is decreased 
from the normal operating pressure (~2.9 Torr) to ~800 mTorr (Figure 2.5). However, the 
increased overlap of the gas flow through the ESI capillary with the MALDI ion generation region 
appears to disrupt the efficiency of ion collection by the ion funnel. In general, the abundances of 
the protein species are ~20-40% lower at each pressure in this experiment compared to the those 
in Figure 2.3 and a dramatic loss in sensitivity is observed as V3 is opened to pressures above 1.0 
Torr. 
 
Figure 2.5: (a) Protein abundance as a function of source pressure for (b) ubiquitin, (c) 
apomyoglobin, and (d) trypsinogen. In c-d, the error bars represent the standard deviation of 3 
replicates. The source pressure was varied by adjusting gas flow through the ESI capillary (V3) 
and the ESI source is positioned to maximize the overlap with the MALDI ion generation region 
(Supplemental Figure 1a). 
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 In order to examine the effect of pressure on transmission efficiency in the absence of off-
axis gas flow, V3 was closed and the pressure was systematically increased by varying V1 (V2 is 
closed). This minimizes the disruption of ion sampling into the funnel by largely eliminating the 
gas flow through the ESI capillary. Without further modifications to the vacuum system, the 
highest achievable pressure using this setup is 800 mTorr. For this experiment, the source was 
again raised to minimize overlap between the ESI capillary and the MALDI ion generation region. 
As the source pressure is increased from 300 to 800 mTorr, protein signal is improved (Figure 
2.6), similar to the experiments in which the pressure was manipulated by adjusting V3. The signal 
abundances between the two sets of experiments are comparable, confirming that there is not a 
significant disruption of ion focusing induced by the off-axis gas flow in Figure 2.3. Also evident 
in Figure 2.6, while adjusting the pressure from the rough pump while the ESI port is closed off, 
is a difference in transmission between singly and multiply charged species. Although there are no 
data for source pressures above 800 mTorr, this observation is again consistent with the effective 
potential being higher for multiply charged ions (Equation 2.1). Finally, there is no significant 
difference in protein signal abundances due to the ESI source position (i.e., ESI capillary not in 
line with the MALDI generation region [Figure 2.6] versus ESI capillary in line with the MALDI 
generation region [Figure 2.7]). This is expected as there is minimal off-axis gas flow emanating 
from the ESI source when V3 is closed and the source pressure adjusted using V1. Only when the 
ESI source is positioned in line with the MALDI ion generation region and V3 opened above 
roughly 1.0 Torr is the off-axis gas flow sufficient to disrupt ion focusing into the funnel. 
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Figure 2.6: (a) Protein abundance as a function of source pressure for (b) ubiquitin, (c) 
apomyoglobin, and (d) trypsinogen. In c-d, the error bars represent the standard deviation of 3 
replicates. The flow through the ESI capillary was minimized (V3 closed) and the source pressure 
was instead varied by adjusting rough pump conductance (V1). The ESI source is positioned to 
minimize the overlap with the MALDI ion generation region.  
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Figure 2.7: (a) Protein abundance as a function of source pressure for (b) ubiquitin, (c) 
apomyoglobin, and (d) trypsinogen. In c-d, the error bars represent the standard deviation of 3 
replicates. The flow through the ESI capillary was minimized (V3 closed) and the source pressure 
was instead varied by adjusting rough pump conductance (V1). The ESI source is positioned to 
maximize the overlap with the MALDI ion generation region. 
 
 
Tissue Imaging and Image Fusion 
 The high mass resolution and accurate mass capabilities of FT-ICR MS have recently been 
used to facilitate protein identification in imaging mass spectrometry experiments.16, 109, 117 While 
this technology is promising for the identification of post-translational modifications (PTMs) and 
the separation of overlapping proteoforms, proteins detected with good signal-to-noise ratios in 
these studies have been limited to m/z values of less than 15,000. Here, we have applied the source 
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conditions optimized as described above for high m/z ion transmission to a protein imaging 
experiment. One half of a transverse rat brain section was imaged using normal source conditions 
(2.9 mTorr) while the second half of the brain was imaged under reduced source pressure 
conditions (750 mTorr). Under normal source conditions, most of the protein species detected are 
in the mass range of m/z 4,000 to 8,500, with a few species detected up to m/z ~14,000 with low 
S/N (Figure 2.7a). However, upon adjusting the source pressure to 750 mTorr using V3, protein 
signals with good S/N are observed from m/z 4,000 to 22,000 (Figure 2.8b). Dramatic 
improvements in S/N are observed at high m/z. For example, the abundance of the singly charged 
species at m/z 14,121.73 is improved by roughly 100-fold using the reduced source pressure 
(Figure 2.9a and 2.9e). Additionally, many other high m/z species that were not detected at normal 
source pressure are observed with good S/N using a source pressure of 750 mTorr (Figure 2.9b-d 
and 2.9f-h). The isotopic envelopes centered at m/z 18,444.60 and 20,712.00 appear to represent 
doubly charged species, indicating that the reduced source pressure condition has enabled the 
detection of proteins with molecular weights over 40 kDa, though the incomplete resolution of 
these isotopic distributions cannot preclude the presence of two overlapping singly charged 
proteins (Figure 2.9f). Given the results from the protein standard experiments in Figure 2.3, it is 
likely that the abundances of protein species below m/z ~11,000 are being slightly attenuated at a 
source pressure of 750 mTorr (attributed to a LMCO effect). Similar to the protein standard 
experiments, the transmission efficiency for multiply charged species is diminished more so than 
that for singly charged species at lower m/z, which is consistent with the effective potential in the 
ion funnel being higher for multiply charged species (Figure 2.9). A more optimal source pressure 
for ions in this mass range is ~1.0 Torr. However, in this imaging experiment we sought to 
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maximize the transmission of the highest m/z species, which occurs at a source pressure of ~750 
mTorr. 
 
 
 
 
Figure 2.8: Average mass spectra from rat brain tissue imaging mass spectrometry experiments 
acquired at source pressures of a) 2.9 Torr and b) 750 mTorr. The source pressure was varied by 
adjusting gas flow through the ESI capillary (V3) and the ESI source is positioned to minimize the 
overlap with the MALDI ion generation region (Figure S1b). Spectra were background subtracted 
and asterisks (*) are used to denote peaks due to electronic noise. c) and d) are 10-fold expansions 
of the intensity scales of (a) and (b), respectively 
. 
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Figure 2.9: Selected mass ranges from Figure 4 showing average mass spectra from rat brain tissue 
imaging mass spectrometry acquired at source pressures of a-d) 2.9 Torr and e-h) 750 mTorr. The 
source pressure was varied by adjusting gas flow through the ESI capillary (V3) and the ESI source 
is positioned to minimize the overlap with the MALDI ion generation region (Figure S1b). 
 
 
 
 Despite the signal attenuation observed for ions at lower m/z, ion images can be produced 
across a broad mass range from m/z 4,000 to 22,000 using the reduced source pressure, roughly 
doubling the mass range for which quality protein ion images can be produced (Figure 2.9). While 
the image quality for proteins in the lower m/z range is comparable between the two source 
conditions (Figure 2.10b-e), the image quality for proteins above m/z ~9,000 is dramatically 
improved at reduced source pressure (Figure 2.10f-o). The spatial distributions of proteins up to 
m/z ~22,000 are clearly visible in many brain substructures including the corpus callosum, white 
matter, granular layer, and molecular layer.  The high mass resolving power of the FT-ICR 
platform allows for clear isotopic resolution of most of these high m/z protein species, and ion 
images are plotted using a ±0.25 Da window of the most intense isotope in order to minimize 
interferences from potentially overlapping isotopic patterns. Using accurate mass measurements, 
tentative identifications for selected ions can be made based on previous reports of rat brain protein 
imaging. For example, the protein ion detected at m/z 5,636.114 can be tentatively identified as 
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ATP synthase subunit epsilon (Figure 2.10c, 4.8 ppm).109 Similarly, the protein at m/z 11,348.33 
can be tentatively identified as doubly acetylated and dimethylated histone H4 (Figure 2.10h, -7.3 
ppm). These post-translational modifications have previously been identified by top-down 
proteomics (N-terminal acetylation, acetylation of lysine 17, and di-methylation of lysine 21).109 
Finally, the ions at m/z 5,653.722 and m/z 11,306.37 are tentatively identified as doubly (2.7 ppm) 
and singly charged (-3.5 ppm) versions of histone H4 that has an N-terminal acetylation and di-
methylation of lysine 21 (Figure 2.10d and 2.10g).109 Imaging mass spectrometry analysis of rat 
kidney tissue was also performed at a reduced source pressure, enabling the detection of protein 
ions up to m/z ~17,000. Similar to IMS analysis of rat brain tissue, high quality ion images are 
obtained here for species above m/z ~9,000 (Figure 2.10). Doubly charged ions are observed up to 
m/z 11,654.37, allowing for the mapping of protein species of molecular weights in excess of 23 
kDa (Figure 2.11d). 
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Figure 2.10: Selected ion images of intact proteins from the mass spectra displayed in Figure 2.9. 
a) An H&E stain of a serial tissue section allows for visualization of brain substructures and 
indicates the hemispheres of the brain that were analyzed using normal source pressure (right 
hemisphere) or reduced pressure source conditions (left hemisphere). b-o) The accurate mass of 
the most abundant isotope and the protein charge state are reported for each of the ion images. 
Internal mass calibration was performed using singly and doubly charged species of cytochrome c 
and hemoglobin α using a quadratic fit. Images are displayed using root-mean-square (RMS) 
normalization. Ion images are plotted as ±0.25 Da for the most intense isotope. Scale bars = 2 mm. 
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Figure 2.11: Selected ion images of intact proteins acquired from protein IMS of rat kidney, which 
was acquired at a reduced source pressure. a) An H&E stain of the tissue section following image 
acquisition allows for visualization of kidney substructures. b-l) The accurate mass of the most 
abundant isotope and the protein charge state are reported for each of the ion images. Internal mass 
calibration was performed using singly and doubly charged species of cytochrome c and 
hemoglobin α using a quadratic fit. Images are displayed using root-mean-square (RMS) 
normalization. Ion images are plotted as ±0.25 Da for the most intense isotope. Scale bars = 1 mm. 
 
  
While the FT-ICR platform facilitates the identification of proteins in an imaging 
experiment, the length of the time-domain signal required to adequately resolve these high m/z 
ions is significant. The 4.47 s transient length used in the imaging experiment shown in Figure 
2.10 provided for a resolving power of ~41,000 at m/z ~17,000, but necessitated over 28 hours of 
instrument time to complete the two 100 µm protein imaging experiments. As the number of pixels, 
and thus image acquisition time, required to sample a given area of tissue is inversely proportional 
to the square of the pixel size,127-131 protein imaging mass spectrometry at higher spatial resolutions 
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using FT-ICR MS quickly becomes time-prohibitive. There is thus specific interest in using data-
driven FT-ICR IMS-microscopy image fusion132 to predict protein ion distributions to a higher 
spatial resolution than that of the original IMS experiment. In order to assess the feasibility of this 
approach, we performed a “spatial sharpening” application of data-driven image fusion, which 
predicts protein ion distributions to a spatial resolution that exceeds that of the measured ion 
images by ten-fold. In this workflow, the IMS protein measurements acquired at 100-μm spatial 
resolution are fused with the H&E microscopy measurements acquired at 10-μm spatial resolution 
in order to predict protein ion distributions at 10-μm spatial resolution (Figure 2.12). This results 
in a single predictive image modality with FT-ICR-grade molecular specificity and microscopy-
grade spatial resolution. These predicted images are accompanied by “reconstruction scores,” 
which are numerical measures of confidence that help assess the reliability of each of the ion 
distribution estimations.132 For example, the successful predictions of protein ions at m/z 
7,650.009, 13,776.35, and 14,313.60 to 10 μm is confirmed with relatively high reconstruction 
scores of 84.47%, 86.11%, and 79.35%, respectively (m/z 7,650.009 shown in Figure 2.12c). This 
proof-of-concept application demonstrates the compatibility of high m/z protein FT-ICR IMS with 
in silico up-sampling techniques such data-driven image fusion, which outperforms common 
bilinear interpolation (data not shown). This example illustrates that predictive computational 
methods hold potential to offset some of the practical constraints incurred by the longer time-
domain transient lengths and limited spatial resolutions used in this work. 
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Figure 2.12: Data-driven, multi-modal image fusion of a) FT-ICR IMS data acquired at 100-μm 
spatial resolution with b) H&E microscopy measurements acquired at 10-μm spatial resolution in 
order to predict c) protein ion distributions at 10-μm spatial resolution. Three protein species with 
relatively good reconstruction scores (>75%) are exemplified here. 
 
 
Discussion 
Modifications to the gas manifold of a 15T FT-ICR MS have enabled control of the gas 
flow and pressure in the MALDI source region. A systematic evaluation of the effect of source 
pressure on ion transmission efficiency through the ion funnel found that reducing the source 
pressure from 2.9 Torr to 750 mTorr improved the transmission efficiency of high m/z protein 
species by 10 to 100-fold. This improvement is attributed to a less dampened effective potential 
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for ion radial confinement at reduced pressures and has enabled the detection of protein standard 
ions up to m/z 24,000. Other observations consistent with previous ion funnel reports, including a 
LMCO effect and differences in the transmission efficiencies of singly and multiply charged ions, 
are also noted. The newly optimized source conditions have been used in an imaging experiment 
to roughly double the mass range for which high quality protein ion images can be acquired from 
rat brain and kidney tissue. The high resolution accurate mass capabilities of FT-ICR MS have 
facilitated the identification of proteins detected in the imaging data. We have used a 
computational tool, FT-ICR IMS-microscopy image fusion, to mitigate the long acquisition time 
associated with FT-ICR protein imaging, required for the resolution of protein isotopic 
distributions, and produce protein images that have both high mass resolution and high spatial 
resolution. 
 
Methods 
Mass Spectrometry 
 All experiments were performed on a 15T solariX XR FT-ICR mass spectrometer equipped 
with an Apollo II dual MALDI/ESI source and a dynamically harmonized ParaCell (Bruker 
Daltonics, Billerica, MA). The MALDI source employs a Smartbeam II Nd:YAG laser system (2 
kHz, 355 nm). Each protein standard mass spectrum was acquired by manually performing a 
random raster of a MALDI spot for 8,000 laser shots. Data were collected from m/z 1,500 to 30,000 
with a resolving power (m/Δm) of ~48,000 at m/z ~17,000 unless otherwise noted (using a 6.71 s 
time-domain transient length) and visualized using Compass DataAnalysis 5.0 (Bruker Daltonics, 
Billerica, MA). The most abundant isotopic mass was selected to determine the ion intensities for 
the protein standard experiments. The ion optics were tuned to maximize high m/z ion 
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transmission, including the funnel RF amplitude (285 Vpp), source octopole (2 MHz, 525 Vpp), 
collision cell (collision voltage: -8.0 V, cell: 1.4 MHz, 1900 Vpp), time of flight delay (3.2 ms), 
and transfer optics (1 MHz, 410 Vpp). The funnel RF amplitude setting is close to the upper 
software limit of this element. The source DC optics were kept constant for all experiments 
(Capillary Exit: 250 V, Deflector Plate: 200 V, Plate Offset: 100 V, Funnel 1: 150 V, Skimmer 1: 
70 V). Gated trapping was used in the ICR cell to more efficiently trap high m/z species:119, 133, 134 
the initial front and rear trapping potentials were set to 2.5 V and ramped down to 1.5 V in 10 ms 
before ion detection. Ion detection was performed using a sweep excitation power of 50%. 
 The source region of the instrument is backed by a rough pump and uses atmospheric gas 
admitted from the open ESI source to maintain a pressure of ~2.9 Torr (~3.9 mbar) in the source 
region. In order to regulate the pressure and gas flow in the source region of the instrument, 3 
minor modifications were made to the gas manifold (Figure 2.1). First, an isolation valve (KF25 
aluminum bellows block valve from Agilent Varian, Santa Clara, CA) was inserted between the 
source rough pump and the vacuum housing. Second, a secondary rough pump (E2M28 rotary 
vane pump from Edwards, Burgess Hill, England) was added to the source region. The 
conductance of this secondary pump was also controlled using an isolation valve. A Pirani 
convection vacuum gauge (CVM211 Stinger from InstruTech, Longmont, CO) was added to 
accurately measure the pressure in the source region. However, the measured pressure is likely 
somewhat different than the actual pressure in the ion funnel, which can vary locally within the 
device.96 Finally, the conductance through the ESI capillary was regulated by removing the ESI 
source and fitting a push-connection of flexible tubing over the end of the ESI capillary. The other 
end of this tubing was connected to a metering valve (Swagelok, Solon, OH) to regulate the gas 
flow into the source region. While the connection to the ESI capillary was not a perfect seal, the 
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fitting was sufficient to provide a minimum source pressure of ~250 mTorr (~0.33 mbar) when the 
metering valve was completely closed. For all experiments herein, altering the source pressure had 
a minimal effect on the pressure of the downstream collision cell and ICR cell. 
Imaging Mass Spectrometry 
Transverse sections of rat brain and coronal sections of rat kidney were collected at 12 µm 
using a CryostarTM NX70 Cryostat (Thermo Fisher Scientific, San Jose, CA, USA) and thaw 
mounted onto indium tin oxide (ITO)-coated slides. Slides containing the tissue sections were 
washed to remove salts and lipids as previously described.135 Briefly, the wash protocol consisted 
of: 70% ethanol (30s), 100% ethanol (30s), Carnoy’s fluid (6:3:1 ethanol:chloroform:acetic acid, 
2 min), 100% ethanol (30s), water (30s), and 100% ethanol (30s). Following the wash, samples 
were dried using a desktop vacuum desiccator for 30 minutes. A DHA matrix layer was then 
applied to the slides using a custom-built sublimation apparatus (110°C, 4.5 minutes, <70 
mTorr).136 Immediately prior to IMS analysis, a matrix recrystallization step was performed to 
improve protein sensitivity (using 1 mL of 1:1, TFA:H2O for 3 minutes at 37 °C).137 Images were 
acquired at a pixel spacing of 100 µm (for brain tissue) and 60 µm (for kidney tissue) in both the 
x and y dimensions using a ~75-µm laser beam (1,000 laser shots).138 Data were collected from 
m/z 1,000 to 30,000 using a 4.47 s time-domain transient length. This shorter length transient 
compared to the protein standard experiments detailed above decreased the time required for image 
acquisition and resulted in a resolving power of ~41,000 at m/z ~17,000. The resulting ion images 
were visualized using FlexImaging 5.0 (Bruker Daltonics, Billerica, MA) and images are displayed 
using root-mean-square (RMS) normalization. All ion images were visualized using interpolation 
except those displayed as part of the image fusion workflow. Following image acquisition, tissue 
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sections were stained using hematoxylin and eosin (H&E) and scanned using a SCN400 brightfield 
digital whole slide scanner (Leica Microsystems, Bannockburn, IL). 
Data-driven Multi-modal Image Fusion 
The availability of both IMS and microscopy measurements (albeit with different pixel 
sizes), enables the use of data-driven image fusion as a means of cross-modal prediction.132 Briefly, 
the mass spectra were normalized on the basis of their total ion current, and baseline corrected 
using a piecewise cubic approximation of the baseline at the 10% quantile of ion intensities, while 
employing a window size of 100 and a step size of 50. The spectra were subsequently peak-picked 
to produce an IMS data source of 1,156 peak ion images, consisting of 11,129 on-tissue pixels in 
total and 1,704 pixels within the highlighted tissue area. These steps were performed using the 
Bioinformatics Toolbox of MATLAB (MathWorks). The microscopy data source was an H&E 
stain of a tissue section serial to the section sampled by IMS and consists natively of the standard 
red, green, and blue intensity bands, which are subsequently expanded to 905 bands using the 
transformations described previously.132 The microscopy source consists of 2,928,451 pixels, 
166,848 of which fall within the highlighted area. The IMS and microscopy data sources were 
spatially registered to each other using a similarity transformation (allows translation, rotation, and 
scaling), as determined by manual selection of corresponding fiducials in MATLAB using the 
cpselect() and cp2tform() functions. The mapping step of the fusion process employed an integer 
2-D Gaussian bell curve centered on the IMS pixel to map microscopy to IMS measurements. 
 The fusion process consists of a model building and evaluation phase followed by a 
prediction phase that then performs the actual estimation of higher-resolution distributions. The 
modeling phase empirically learns a partial least squares linear regression model from the linked 
IMS and microscopy measurements, yielding an IMS/microscopy model that captures how the ion 
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intensity of certain ion species changes when the values of one or more microscopy variables 
change. The reliability of this model in capturing relationships between observations in IMS and 
observations in microscopy is evaluated for each mass spectral peak individually using several 
figures of merit (e.g., reconstruction scores).132 Prediction to a higher spatial resolution is 
performed only for those ions that are identified to have high predictive capability. For example, 
in the workflow described here, m/z 7,650.009, 13,776.35, and 14,313.60 all yielded good 
connection to the H&E microscopy, as reported by reconstruction scores of 84.47%, 86.11%, and 
79.35%, respectively. For these ions, the prediction phase of the fusion workflow performed 
prediction to 10-μm spatial resolution. 
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CHAPTER III 
 
SPATIALLY TARGETED PROTEOMIC ANALYSIS FROM TISSUE USING LIQUID 
EXTRACTION SURFACE ANALYSIS 
This chapter was adapted from the previous published Ryan et al., Rapid Communications in 
Mass Spectrometry, Copyright 2018 by Wiley 
 
Overview 
Liquid extraction surface analysis (LESA) can be used to generate spatially-directed 
protein identifications in an imaging mass spectrometry workflow. This approach involves the use 
of robotic micro-extractions coupled either directly to online liquid chromatography or collected 
for offline LC analysis. Robotic liquid surface extractions are reproducible across various tissue 
types, providing significantly improved spatial resolution, with respect to extractions, while still 
allowing for a robust number of protein identifications. A single 2 µL extract allows for the 
identification of over 14,000 peptides with little sample preparation, increasing throughput for 
spatially targeted workflows. The utility of tissue surface extractions and liquid chromatography, 
offers a new and effective approach to provide spatial proteomics data in an imaging experiment.   
 
Introduction 
Since the emergence of MALDI IMS11, the field has seen tremendous growth in a diverse 
range of research areas including the proteomic study of diseased tissue139, 140, drug 
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development141, 142, and biomarker detection.143, 144 IMS analysis relies on the systematic 
interrogation of a sample, generally a thin tissue section, to generate individual mass spectra at 
discrete x,y- positions. This process gives rise to the spatial mapping of thousands of proteins, 
lipids, and small molecules within a biological sample.145  
Molecular identification in an IMS experiment is crucial in determining the physiological 
role of the detected analytes in the system being studied. Typically, protein IMS experiments have 
been carried out using TOF instruments due to the platform’s high sensitivity over a broad mass 
range, high data acquisition speeds, and relatively low cost. However, identifying proteins during 
MALDI-TOF IMS analyses can be challenging. Ideally, protein ions would be analyzed and 
sequenced by tandem mass spectrometry (MS/MS or MSn) directly from tissue. Generating useful 
fragmentation data becomes difficult at the higher m/z values (> ~3000). A second approach for 
identification during an imaging experiment is the use of high resolution accurate mass 
measurements to unambiguously identify the empirical chemical formula for the ion of interest. 
However, collecting accurate mass measurements using MALDI-TOF platforms is difficult 
because of their limited mass accuracy (typically >20 ppm) and lower mass resolving power, 
particularly for high m/z ions (i.e., > 3000).146 Recently, high resolving power, high mass accuracy 
FT-ICR MS has been used to help link identifications through accurate mass measurements to LC-
MS/MS proteomics data and TOF-based imaging experiments.15, 16, 40, 41 For example, in recent 
studies, we were able to detect intact proteins up to 20 kDa, with resolving powers of ~75,000 at 
m/z 5,000 and mass accuracies < 5ppm.41 Although progress has been made, the identification of 
proteins from tissue still remains a difficult task. 
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Due to the practical issues associated with fragmenting ions directly from tissue, protein 
identifications for MALDI IMS experiments are often achieved by performing secondary LC-
based experiments to complement the IMS data.147 By identifying analytes in a secondary 
experiment, identifications can be correlated back to the imaging data through the matching of 
intact molecular weights.35, 148, 149 These complimentary experiments typically fall into 3 
categories: 1) bulk tissue homogenization and protein extraction, 2) enzymatic digestion 
performed directly on tissue followed by MS/MS of the resulting peptides, and 3) spatially-
targeted surface extractions of peptides or proteins. In the bulk homogenization experiment, the 
entire tissue or tissue section is homogenized, proteins are extracted and further subjected to 
bottom-up LC-MS/MS or top-down approaches.150 Although the more common approach, bottom-
up identifications are often difficult to correlate back to IMS data of intact proteins because the 
intact mass information, and post translational information is often lost during the bottom-up 
experiment. Also, all spatial information is lost during the homogenization process. Another 
approach is to perform on-tissue enzymatic digestions.  An enzyme is applied to the sample in a 
way that minimizes analyte delocalization on the tissue surface, and proteins are sequenced 
directly using MALDI MS/MS. 151 These experiments suffer from low throughput as they require 
additional sample manipulation, relative to intact protein analysis, and each peptide is usually 
sequenced individually. These bottom-up workflows are also susceptible to missing post 
translational modifications (PTM) information due to mass mismatches with the IMS data and 
missing peptides. Finally, spatially-directed approaches, such as enzyme-loaded hydrogels and 
liquid extraction surface analyses (LESA), allow for the interrogation of discrete regions of the 
tissue surface, retaining the spatial integrity of an IMS analysis. Hydrogels, small gel polymers 
that are loaded with trypsin and placed on a tissue for digestion and extraction of peptides and have 
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been shown to be an efficient method of generating protein identifications but are difficult to 
manipulate due to their small size.72, 74, 152 LESA workflows involve the dispensing of small 
volumes of solvent onto the tissue surface, allowing for the diffusion of analytes into the liquid 
which can be followed by traditional proteomic workflows providing for a sensitive, high-
throughput approach to performing spatially targeted proteomics experiments.153  
Liquid micro-extractions between a tissue surface and solvent droplet have been shown to 
produce robust LC-based proteomics results.154 Schey et al. manually pipetted 1 µL volumes of 
solvent onto a tissue surface and detected upwards of 100 intact protein signals by simply 
aspirating and re-dispensing the solvent on the tissue surface multiple times and then subjecting 
the extraction to top-down LC-MS/MS.75 This approach is useful when attempting to study a tissue 
sample in a spatially targeted manner as the sample is kept intact while targeting discrete regions 
for analyses. A semi-automated approach uses a robotic pumping and positioning system to sample 
the surface of a substrate with greater accuracy and precision.155-160 It’s ease of use, reproducibility, 
automated functionality, and ability to interrogate discrete regions of a sample has been 
demonstrated for analyzing several classes of biomolecules from a range of surfaces, including 
tissue, dried blood spots, food surfaces, and latent fingerprints.161-164  Previous studies have shown 
the capabilities and application of LESA, which utilized disposable capillary tips and enabled 
offline proteomics analysis of tissue extracts.155-158, 161-164 Recently, this liquid extraction 
technology has been modified to replace the disposable capillary with a glass capillary 
(LESAplusLC) allowing for increased droplet resolution on the sample surface. The capillary 
outlet is fed into a 6-port valve where the sample can be injected onto a column for online LC-MS 
analysis.165  
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Herein, we report the coupling of robotic surface micro-extractions from thin tissue 
sections directly to LC-MS and LC-MS/MS using a glass capillary setup. Extractions are 
completed and taken offline for bottom-up MS analysis to assess the extraction process and 
determine its efficiency and robustness. This methodology provides improved reproducibility and 
droplet resolution when compared to previous methods using hand pipetting, and has been 
incorporated directly into online LC-based workflows. The enhanced micro-extraction process 
allows for the use of both bottom-up and top-down approaches, with a higher throughput than 
previous IMS protein identification workflows. 
 
Results 
Surface Extraction Performance 
In order to visualize the effect of solvent composition on droplet resolution, various 
combinations of solvents were tested using an increasing volume of extraction solvent while 
dispensing onto water sensitive paper using the LESAplusLC platform (Figure 3.1 and Table 3.1). 
Three replicates were measured to assess the reproducibility of the droplet diameters. For 100% 
H2O, the average extraction volume diameter on water sensitive paper is below 600 µm for the 
smallest extraction volume (0.5 µL), ~70% smaller than previous efforts using manual pipetting.75 
We also see an improvement in droplet resolution compared to the older, air-infused mandrel for 
the LESA experiments. The prior setup yielded an average spot size of 2.2 ± 0.04 mm dispensing 
1:1 ACN:H2O (~50% decrease in resolution). However, the spot size increases significantly with 
increasing percentages of organic solvents and extraction volume. LESA droplet sizes were also 
assessed on tissue using hematoxylin stain (Table 3.1). The values measured from the on-tissue 
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experiment are slightly larger than their water sensitive paper counterparts. This is mainly due to 
the water-sensitive paper being more hydrophobic than the tissue, allowing the surface tension of 
the liquid to maintain a smaller droplet profile. Even though the dispensing/aspiration step was 
held for twice as long as the water sensitive paper tests in order to allow for the stain to penetrate 
the cells, no change in diameter was observed using the increased dispensing time for the on-tissue 
measurements. The spot size measurements from tissue were 1.23 mm (5.6% RSD), 1.78 mm 
(4.5% RSD), 2.29 mm (2.2% RSD), and 2.55 mm (3.2% RSD) for 0.5, 1.0, 1.5, and 2.0 µL 
extraction volumes, respectively. These results demonstrate the reproducibility of a LESA 
experiment, and improvements compared to similar techniques, with regards to droplet resolution.  
 
Figure 3.1: A) The measured droplet resolution of the LESAplusLC system on water-sensitive 
paper decreases as the volume dispensed increases and as the relative organic fraction of the 
solvent increases. B) The measured droplet resolution of the LESAplusLC system on rat brain 
tissue (cerebellum) using hematoxylin stain to visualize the solvent diffusion during extraction. 
For both experiments, droplet diameter measurements were made using bright field microscopy.  
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Table 3.1: Droplet resolution of the LESAplusLC system as measured from water sensitive paper 
and tissue sections (rat brain cerebellum). Measurements were made varying solvent composition 
and volume dispensed (n=3). 
 
 
In order to determine the reproducibility of the proteomic extraction from the tissue using 
the glass capillary mandrel, extractions were performed from rat brain cerebellum following on-
tissue proteolytic digestion using trypsin. A single, 2 µL volume was dispensed/aspirated 5 times 
(75 seconds total) onto the tissue surface, and subjected to offline, bottom-up LC-MS/MS where 
an average of 1620 proteins were identified across the 5 replicates. These results showed that the 
extraction was extremely reproducible with a relative standard deviation of 2.7% (1st Replicate: 
1560 unique proteins, 2nd Replicate: 1661 unique proteins, 3rd Replicate: 1615 unique proteins, 4th 
Replicate: 1603 unique proteins, 5th Replicate: 1662 unique proteins) between the 5 samples. It is 
also important to maintain sensitivity at decreasing spot size in order to allow for the interrogation 
of smaller foci. The overall sensitivity and reproducibility of the LESAplusLC platform was 
58 
 
assessed by measuring the total number of proteins identified and peptides observed from tissue 
as a function of extraction volume. Figure 3.2 highlights the results from triplicate surface 
extractions that were completed using 2.0, 1.5, 1.0, and 0.5 µL volumes of 1:1 ACN: H2O (0.5% 
FA) from the cerebellum of a rat brain that had been digested overnight using trypsin. This solvent 
composition was selected for these experiments based on previous tissue extraction experiments 
in our lab. The total number of peptides observed across the interrogated volumes, from largest to 
smallest, were 8475 ± 331 (2.0 µL, RSD 3.9%), 8361 ± 361 (1.5 µL, RSD 4.3%), 7791 ± 568 (1.0 
µL, RSD 7.3%), and 4837 ± 933 (0.5 µL, RSD 19.3%) peptides. The total number of protein 
identifications were found to be 1165 ± 55 (RSD 4.7%), 1175 ± 43 (RSD 3.7% RSD), 1119 ± 48 
(RSD 4.3%), and 860 ± 104 (RSD 12.1%) as LESA volumes are varied from 2.0-0.5 µL. The 
relative standard deviations across both the peptide and protein replicates were found to be quite 
low for most volumes (RSD < 5%), with even the smallest droplet size experiments (0.5 µL) 
having an RSD of just over 12%.  
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Figure 3.2: The number of unique proteins identified from digested rat brain cerebellum decreases 
as the volume dispensed on tissue is decreased, and is reproducible across volumes dispensed 
(n=3).  
 
 One of the advantages of utilizing an automated liquid surface extraction platform is the 
ability to increase throughput, minimizing sample preparation time and allowing for multiple 
extraction experiments to be completed in a single experiment. Comparing the LESA experiment 
to a similar, spatially-targeted technology such as hydrogels highlights the increase in throughput 
achieved. Whereas the typical hydrogel experiment takes ~2-2.5 days to complete, the LESA 
workflow takes ~1 day for bottom-up and ~2 hours for top-down analysis. A hydrogel experiment 
requires the casting of the gel (~16 hours), reswelling and gel placement (~1-2 hours), digestion 
(~14 hours), and extraction and LC-MS/MS analysis (~1-2 hours). The bottom-up LESA 
experiment can be completed in ~16 hours total. This includes the overnight digestion and LC-
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MS/MS runs. The number of identifications are comparable to other spatially targeted approaches 
such as hydrogels. A hydrogel fabricated with a diameter of 1.66 mm has been shown to be capable 
of identifying 1052 proteins, while the LESA experiment at 1.0 µL (~1.71 mm diameter measured 
previously) identified 1119 proteins.74 The top-down experiments can be completed in as little as 
1-2 hours, where the majority of the time is devoted to LC-MS/MS analysis, as the tissue washes 
and extractions only take  ~10 minutes to complete. For both bottom-up LESA methodologies, the 
analyte extraction steps require minimal time (~10 minutes) relative to the digestion (overnight) 
and LC-MS/MS (~1-2 hour) steps. This improved throughput allows multiple LESA experiments 
to be performed rapidly, enabling the generation of multiple extractions and analyses from a single 
tissue section.   
LESA also has the advantage of allowing for sequential surface extractions to effectively 
‘build-up’ analyte concentrations enabling both detection and structural identification by MS/MS 
even for low abundance species. This is particularly important for tissue analysis where the 
abundance of analytes can vary orders of magnitude across the surface. To determine the total 
amounts of extractable proteins gathered in sequential liquid surface extractions, peptides were 
extracted from the cerebral cortex of a trypsin-digested rat brain. A single 2 µL extraction was 
gathered from the cerebral cortex and collected for offline LC analysis. Following this, the tissue 
was allowed to dry and another extraction was then collected from the same spot and analyzed 
separately. This process was repeated 5 times and the total peptide and protein identification counts 
were compared across each subsequent extraction (Figure 3.3). It is evident that after the initial 
extraction, the losses in both peptides observed and proteins identified are substantial. Between 
the 1st and 2nd extractions there is a decrease of approximately 30% and 42% in the peptides and 
proteins identified, respectively. By the 5th extraction a total decrease of 96% (peptides) and 98% 
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(proteins) from the 1st extraction is observed. Between the 1st and last extraction, there are no new 
species being detected, only a loss in identifications of proteins detected in the prior runs. As there 
are no new species being detected, the results suggest that after the 2nd extraction from the same 
spot the results are diminishing, and combining subsequent extractions after this is unnecessary. 
However, the ability to perform multiple extractions at the same spot is important for improving 
sensitivity and generating sufficient signal to produce quality MS/MS data from liquid surface 
extractions. 
 
 
 
Figure 3.3: Five LESA extractions gathered sequentially from the same spot on trypsin-digested 
rat brain that show a decrease in unique protein identifications and peptides identified through 
sequential extractions.  
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Correlating IMS with LESAplusLC Protein Experiments 
 Coupling LESAplusLC with LC-based experiments provides a high throughput method for 
generating spatially-targeted proteomics data for the various proteins and proteoforms observed in 
imaging MS experiments by minimizing sample preparation and time between experiments.  In 
order to determine the efficacy of coupling LESA directly to LC-MS/MS to analyze intact proteins 
from tissue, full body tissue sections of mouse pup were prepared. Full body tissue sections serve 
as an excellent sample to test this spatially-targeted workflow because there are many large 
heterogeneous substructures in the tissue that can be easily targeted for analysis using the 
LESAplusLC system without the risk of collecting data from overlapping regions. 
 
 
Figure 3.4: A sagittal section of mouse pup was imaged at 125 μm in order to determine regions 
rich in protein signal. An overlay of four ions, m/z 4898.57, m/z 5675.21, m/z 6628.37 and m/z 
7513.88,  were selected to detail the various substructures of the mouse pup tissue section. Based 
on intensity and localization of protein signals, the kidney, cerebellum, and cerebral cortex were 
chosen for interrogation by LESA.  
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A full body protein image from a mouse pup was acquired on a 15T FT-ICR MS at 125 
μm spatial resolution. The data showed a number of unique protein distributions, including m/z 
4,898.57, m/z 5675.21, m/z 6,628.37, and m/z 7,513.88 (Figure 3.4). MALDI FT-ICR protein 
data provide the spectral quality necessary to fully resolve the isotopic envelopes and provide 
high mass accuracy for the observed ions. Based on these results, the cerebellum, cerebral cortex, 
and kidney were chosen for interrogation using spatially targeted surface extractions. Adjacent 
serial tissue sections of the mouse pup were used for LESAplusLC extractions for both bottom-
up and top-down experiments. For the bottom-up analysis, two separate, 2 μL surface extractions 
were combine for each target area. The aliquots were dried down and reconstituted into 10 μL of 
H2O (0.5% FA) prior to analysis. The results are presented in Figure 3.5 and Table 3.2 using a 
Venn diagram to compare the total number of protein identifications and a table highlighting 
some of the proteins identified that are unique to the area sampled. Both the cerebellum and 
cerebral cortex extractions yielded a large number of identifications proteins respectively, many 
of which were identified in both substructures of the brain (1536). Interestingly, the kidney 
produced far fewer protein ID’s than the other two areas sampled.  
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Figure 3.5: Proteins identified from 3 regions of a mouse pup tissue section by combining 2 liquid 
surface extractions from the same spot. In total, 2879 proteins were identified from the cerebral 
cortex, 2290 proteins were identified from the cerebellum, and 602 proteins were identified from 
the kidney. The 3 regions tested displayed overlaps in the proteins identified as highlighted in the 
Venn diagram.  
 
 
 
 
 
Table 3.2: Selected proteins identified from LESAplusLC extracts that are unique to the cerebral 
cortex, cerebellum, and kidney in mouse pup full body tissue sections. 
 
Spatially targeted liquid surface extractions were also used to generate top-down data from 
full body mouse pup tissue sections. Here, two separate 2 µL surface extractions were combined 
for each target area prior to offline LC-MS/MS analysis. Top-down results were initially processed 
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using the proteomics search engine Byonic optimized for ETD data. The results from these 
searches identified 27, 33, and 38 intact proteins from the kidney, cerebral cortex, and cerebellum, 
respectively, out of a total of 81, 69, and 72 intact protein species detected during LC-MS/MS 
analysis. Based on these results, selected proteins were then chosen for de novo manual 
interpretation guided by the database results to improve overall sequence coverage (Figure 3.6). 
Proteins detected in the imaging experiment were correlated to identifications from the top-down 
data by matching the intact accurate masses of the two experiments to within 2 ppm. The ion at 
m/z 4,936.540 was determined to be N-term Acetylated Thymosin β10 (0.36 ppm), a protein that 
has been shown to bind and sequester G-actin (Figure 3.6D).166 Thymosin β10 is a known to be 
abundant in brain tissue and was found localized mainly to cerebral cortex (Figure 3.6C).167 The 
ion at m/z 5707.118 was determined to be ATP synthase subunit ε (-1.08 ppm). ATP Synthase is 
a general mitochondrial protein responsible for converting ADP to the ATP (Figure 3.6F) and can 
be localized to many different tissue types.168, 169 This protein was found to be localized to all 3 
targeted regions (Figure 3.6E). The ion observed at m/z 7023.974 in the MALDI IMS data was 
identified as the N-terminally acetylated form of Histone H2A (-0.56 ppm) (Figure 3.6H) in its +2 
charge state. This ion was found to be localized in the cerebellum and kidney (Figure 3.6G). 
Histone H2A plays an important role in the folding of DNA in chromatin170 and is known to be 
elevated in tissue that has undergone trauma or disease.171 Here it was found localized to the 
cerebellum and kidney regions. The dimethylated form of hemoglobin subunit A was determined 
to be the ion at m/z 7491.884 (-1.41 ppm), in its +2 charge-state, and can be seen localized to the 
kidney (Figures 3.6I and 3.6J). Subunit A is one of the 4 major subunits that make up hemoglobin, 
an important oxygen-transporting metalloprotein found in red blood cells, which are produced in 
the kidney.172, 173 The mass range of the proteins identified span from 4,500 to 18,000 Da. From 
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the 4 proteins identified by top-down sequencing, 3 were found to be correlated to the 3 regions 
subjected for bottom-up mass spectrometry in the prior section. Thymosin beta-10 was not found 
to be in any of the bottom-up extractions. 
A unique advantage of the LESAplusLC system is the ability to perform online LC-MS 
experiments with a surface extraction. This feature maximizes throughput and minimalizes 
potential sample loss during preparation steps. In order to test the performance of this 
methodology, intact proteins were extracted from the same three target areas mentioned above 
(cerebellum, cerebral cortex, and kidney) within the full body mouse pup tissue section and 
subjected to online LC-MS in triplicate. A single 2 µL extract was gathered by dispensing the 
extraction volume five times (15 s each) onto the tissue surface and then automatically injecting it 
onto the sample loop directly. The total number of proteins detected for each run (S/N > 3) was 
determined using the deconvoluted average mass spectra over the entire LC experiment (select 
chromatograms for each target area are depicted in Figure 3.7). From the cerebellum a total of 60 
± 6 proteins were detected while the kidney and cerebral cortex yielded 57 ± 13, and 52 ± 15 
respectively. Though the relatively slow scan time of the FT-ICR prevented LC-MS/MS 
identification, the number of protein species detected are comparable to previous methods using 
hand pipetting.75 Additionally, although previous studies have demonstrated online LC-based 
analysis from liquid surface extractions using home-built systems, 159, 160 this is the first example 
of this capability being demonstrated for proteins using the commercial LESAplusLC platform. 
Future studies will examine implementing this online workflow on a MS platform more amenable 
to top-down LC-MS/MS experiments. 
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Figure 3.6: A & B) Spectral and imaging data from a 125 µm spatial resolution MALDI protein 
image from a sagittal section of a mouse pup acquired on a 15T FT-ICR MS. Four ions were 
chosen to exemplify the many tissue substructures present as highlighted in the image overlay (B). 
The proteins sequenced below are highlighted by a star in the average mass spectrum of the protein 
image. C & D) The high resolution, top-down mass spectrum of m/z 4,898.57 allows for its 
identification as N-acetylated Thymosin β10. E & F) The high resolution, top-down mass spectrum 
of m/z 5,675.21 allows for its identification as ATP synthase subunit ε. G & H) The high resolution, 
top-down mass spectrum of m/z 6,628.37 (+2) allows for its identification as N-acetylated histone 
H2A Type 1. I & J) The high resolution, top-down mass spectrum of m/z 7,513.88 (+2) allows for 
its identification as dimethylated hemoglobin subunit A.  
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Figure 3.7: Total ion chromatograms (TIC) from the selected tissue regions from mouse pup 
analyzed by LESAplus coupled to online LC-FT-ICR MS.  
 
 
Discussion 
 This work has demonstrated the capabilities of robotically-controlled, spatially-
targeted liquid surface extractions coupled to online and offline proteomics workflows for 
identifying proteins observed in imaging mass spectrometry experiments. A number of 
experimental characteristics were measured to assess the efficiency of the LESAplusLC extraction 
including extraction spot size, number of peptides detected, and number of proteins identified 
across multiple experiments. Utilization of a glass capillary for extractions allows for improved 
droplet resolutions (< 600 µm on water sensitive paper) and reproducibility (relative standard 
deviations of < 5%) for most experiments. Comparisons of spatially-targeted proteomic techniques 
such as hydrogel experiments, laser capture laser microscopy (LCM), and tissue homogenization  
have been discussed elsewhere.74 In these studies, 1.5 mm LCM, 1.5 mm tissue punch/digestion, 
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and 1.67 mm hydrogel experiments yielded ~800-1000 protein identifications whereas the 1.0 µL 
LESA experiment (1.71 mm on tissue) described herein yielded ~1120 protein identifications. 
Although a modest improvement in the number of protein identifications, the LESAplusLC 
workflow is a significant improvement in throughput relative to other approaches. Hydrogels, 
tissue punches, and LCM are all time-consuming experiments, while the automated LESA 
extraction can generate samples, ready for LC-MS/MS analysis, in ~10 minutes. Additionally, the 
tissue is preserved during LESA experiments, allowing for sequential extractions that effectively 
improve the sensitivity of the technique. Finally, direct coupling of LESAplusLC to HPLC allows 
for the generation of online LC-MS data directly from tissue with minimal sample preparation. 
Using only a single 2 µL extraction, we were able to detect upwards of 60 proteins from various 
regions of tissue. Robotic liquid micro-extractions allow for a more reproducible approach to 
generating protein identifications to complement an IMS workflow. The combination of robotic 
extraction and online LC technologies allows for the rapid collection of spatially-targeted protein 
identifications that can be correlated to imaging MS data using accurate mass-matching. The 
spatial sampling precision, coupled with robustness and reproducibility, make the LESAplusLC 
technique more suitable for high-throughput spatial proteomic experiments than previous manual 
methodologies and will aid in the challenge of identifying proteins observed by MALDI IMS. 
 
Methods 
Tissue Preparation 
One week old C57BL/6 control mice that had been stored at -80 °C were shaved over dry ice to 
remove as much hair as possible to avoid contamination during sample preparations and IMS. 
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Frozen rat brain was purchased from Pel-Freeze Biologicals (Rogers, AR, USA), and was stored 
at -80 °C until sectioning. In all cases, tissue was sectioned (12 µm thickness) at -15 °C using a 
CryoStarTM NX70 Cryostat (Thermo Fisher Scientific, San Jose, CA, USA), thaw mounted onto 
conductive indium-tin-oxide coated slides (Delta Technologies), and dried in a vacuum desiccator 
for at least 20 minutes prior to preparation for analysis. To maximize sensitivity for proteins and 
peptides, tissue sections underwent a washing protocol to remove lipids and salts. The wash steps 
included 70% ethanol (30s), 100% ethanol (30s), Carnoy’s Wash (6:3:1 ethanol:chloroform:acetic 
acid), 100% ethanol (30s), water (30s), and 100% ethanol (30s) as described previously.174 Animal 
husbandry and experimental procedures were conducted in agreement with Public Health Service 
policy and approved by the Vanderbilt University School of Medicine Institutional Animal Care 
and Use Committee. 
MALDI IMS 
For imaging experiments, MALDI matrix (DHA) was applied to the sample using a robotic sprayer 
(TM Sprayer, HTX Technologies, Carrboro, NC, US) at a concentration of 15 mg/mL in 9:1, 
ACN:H2O. The sprayer nozzle was set to spray at 80 °C using a carrier solvent of 9:1 ACN:H2O 
at a flow rate of 0.1 mL/min and a drying sheath gas of dry nitrogen set to 10 psi. Four passes of 
matrix were applied using alternating offsets (1 mm) and directional rotations (90 degrees) with a 
2 mm track spacing. The spray velocity was set to 1100 mm/min with a 2 s dry time between 
passes and 40 mm nozzle height. The matrix layer on the sample was recrystallized prior to 
MALDI analysis as previously described using 1.0 mL of 1:1, TFA:H2O at 37 °C for 3 minutes.20 
The image was acquired in positive ion mode at 125 µm spatial resolution on a Bruker SolariX 
15T FT-ICR MS (Bruker Daltonics, Billerica, MA, USA). The instrument employs a Smartbeam 
II 2 kHz frequency tripled Nd:YAG (355 nm) laser, as well as an Apollo II dual MALDI/ESI ion 
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source. Each pixel was the sum of 2000 laser shots, using the smallest laser focus (~50 µm), while 
random-walking the target within the 125 µm pixel. The mass spectrometer was externally 
calibrated prior to analysis using a protein mixture (insulin, cytochrome C, trypsinogen, and 
apomyoglobin). Data were collected from m/z 1,385 - 20,000 with a time-domain file size of 512K 
(FID length: 1.6078 s), yielding a resolving power of ~42,000 at m/z 5000. In order to generate an 
image with a higher mass range, the ion optics were tuned as follows: accumulation hexapole (1.4 
MHz, 1700 Vpp), time-of-flight delay (2.1 ms), funnel RF amplitude (200 Vpp), transfer optics (2 
MHz, 380 Vpp), and ICR cell (sweep excitation power: 40%).  
In Situ Tryptic Digestion 
Trypsin was dissolved into 333 µL of ammonium bicarbonate (100 mM, pH~8.50), 67 µL of acetic 
acid (100 mM), and 40 µL of acetonitrile to a final concentration of 0.045 µg/µL. The sample was 
sprayed at a temperature of 30 °C using the TM Sprayer for 8 total passes using alternating 
directional rotations and offsets. The sprayer used a flow rate of 0.0075 mL/min, with a 2 mm 
track spacing, a nozzle height of 40 mm, and a velocity of 700 mm/min using a syringe pump.149 
Immediately following trypsin application, samples were left to digest overnight at 37 °C in a 
covered dish that contained 3 mL of 100 mM ammonium bicarbonate. 
Tissue Extractions 
Tissue extractions were completed using the TriVersa NanoMate (Advion, Inc., Ithaca, NY, USA) 
modified to include a glass capillary (LESAplusLC) for improved spatial resolution and online 
integration with LC-based experiments.165 Scanned images of thaw-mounted samples were 
uploaded to the ChipSoft Software (Advion, Inc., Ithaca, NY, USA) to allow histological regions 
of interest to be selected for analysis. For online LC-MS analysis of intact proteins, extractions 
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were completed by aspirating 3 µL of extraction solvent (1:1 ACN:H2O with 0.5% FA) and 
dispensing 2 µL on tissue. The dispensed extraction solvent was left on tissue for 15 s prior to re-
aspiration back into the capillary. This process was repeated 5 times, after which the capillary was 
moved back to the solvent well to draw enough solvent to load the sample into the sample loop 
(~6 µL volume) on a 6-port HPLC valve. All extractions were completed by dispensing the volume 
from the capillary at a height of 0.5 mm above the surface of the sample. For top-down experiments 
not directly coupled to the LC, extractions were completed in the same manner but deposited into 
a single well of a 96-well plate that contained 15 µL of H2O (0.5% FA). The contents of that well 
were then injected onto the column immediately for LC-MS analysis (see below for details).  
For peptide extractions, on-tissue tryptic digestion was performed as described above. For 
all bottom-up offline experiments, a combination of 1:1 ACN:H2O (0.5% FA) was used as the 
extraction solvent. Extractions were all completed using an initial aspirated volume of 3.0 µL while 
varying the total amount dispensed on tissue. Instead of being pulled into the 6-port valve for the 
dispensing/aspirating, the aliquots were deposited into a single well of a 96-well plate that 
contained 100 µL of H2O (0.5% FA). Samples were dried down using a desktop vacuum centrifuge 
(Thermo Fisher Scientific, San Jose, CA, USA) and stored at -80 °C until analysis. For the droplet 
resolution experiments, hematoxylin stain was used for the extraction solvent as the liquid can 
penetrate the cell nucleus, allowing for visualization of solvent diffusion and measurement of 
extraction spot size on rat brain tissue. Extraction solvents were able to interact with the surface 
for 30 seconds and repeated twice to ensure the stain had enough time to penetrate the cells.  
Additionally, extraction spot size measurements were made by dispensing varying volumes of 
solvent onto water sensitive paper (Rittenhouse, St. Catherines, Ontario, CA). Following spot size 
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experiments, the tissue sections or water sensitive paper were left to dry under vacuum and spot 
size measurements were made using an optical microscope (Olympus, Center Valley, PA, USA). 
Online LC-MS 
 For the online LC-MS experiments, proteins were eluted using an analytical column which 
was packed with 20 cm of C4 reverse phase material (Halo Protein C4, 3.4 µm, 400Å) with a laser-
pulled emitter tip. Proteins were loaded on the capillary reverse phase analytical column (360 µm 
O.D. x 150 µm I.D.) using a Waters nanoACQUITY UPLC (Waters Corporations, Milford, MA, 
USA) where mobile phase A consisted of 0.1% formic acid, 99.99% water, and mobile phase B 
consisted of 0.1% formic acid, 99.99% acetonitrile, eluting at 0.600 µL/min. Ions were generated 
using a Bruker Captive Spray nanoelectrospray source (Bruker Daltonics, Billerica, MA, USA) 
and directed into a Bruker SolariX 15T FT-ICR MS (Bruker Daltonics, Billerica, MA, USA). The 
mass spectrometer was set to scan from m/z 230-2,000, with a file size of 1M yielding a resolving 
power of 150,000 at m/z 400 (FID length: 0.5243 s). Ion optics were tuned as follows: 
accumulation hexapole (2 MHz, 1200 Vpp), time-of-flight delay (0.8 ms), funnel RF amplitude 
(280 Vpp), transfer optics (4 MHz, 290 Vpp), and ICR cell (sweep excitation power: 18%). 
Bottom-Up Tandem Mass Spectrometry 
Bottom-up mass spectrometry was employed to identify proteins from targeted regions 
detected during IMS analysis of the mouse pup and to characterize the efficiency of various 
extraction conditions on brain tissue. For the mouse pup experiment, tryptic peptides from the 
tissue extracts were injected and gradient eluted on a pulled tip emitter column (360 μm O.D. x 
100 μm I.D. x 35 cm) packed in-house with C18 material (Waters BEH C18, 1.7 μm, 130 Å). The 
column was heated to 60 °C with a flow rate of 400 nL/min during operation using an Easy-nLC 
78 
 
1000 UHPLC (Thermo Scientific, San Jose, CA, USA), where the mobile phase A consisted of 
0.1% formic acid, 99.9% water, and mobile phase B consisted of 0.1% formic acid, 99.9% 
acetonitrile. Peptides were eluted on the reverse phase column using a linear gradient of 2-20% B 
for 100 minutes, followed by 20-32% B for 20 minutes, and lastly 32-95% B for 1 minute. An 
Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific, San Jose, CA, USA) was used to 
mass analyze the eluting peptides. MS1 scans were acquired using the Orbitrap at 120k resolution, 
a mass range of 400-1600 m/z, an automatic gain control (AGC) target of 1.0x106, and a maximum 
injection time of 100 ms. The top 17 most abundant ions measured in the MS1 scans were then 
mass isolated using a quadrupole mass filter at 2 m/z window width to undergo fragmentation in 
the HCD cell using 35% normalized collision energy. The fragmented ions are subsequently mass 
analyzed in the linear ion trap using an AGC target of 1x104, a maximum injection time of 35 ms, 
and the normal scanning rate setting. Dynamic exclusion of 30 s was used for all MS2 scans. For 
identification of peptides, tandem mass spectra were searched using Protalizer software (Vulcan 
Analytic, Birmingham, Alabama, USA) against a rat database created from the UniprotKB protein 
database (www.uniprot.org). Variable modifications such as carbamidomethyl, phosphorylation, 
methionine oxidation, and deamidation were included in the database search. Proteins were 
identified with at least 2 unique peptides per protein, with a false discovery rate of 1%. 
 For the extraction characterization experiments, an analytical column was packed with 22 
cm of C18 reverse phase material (Jupiter, 3 μm beads, 300Å, Phenomenox) directly into a laser-
pulled emitter tip (Sutter Instrument Company, Novato, CA, USA).  Peptides were loaded on the 
capillary reverse phase analytical column (360 μm O.D. x 100 μm I.D.) using a Dionex Ultimate 
3000 nanoLC and autosampler.  The mobile phase solvents consisted of 0.1% formic acid, 99.9% 
water (solvent A) and 0.1% formic acid, 99.9% acetonitrile (solvent B).  Peptides were eluted with 
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a gradient at a flow rate of 350 nL/min.  The 95 minute elution was performed as follows: 1-3 min, 
2% B (sample loading from autosampler); 3-78 min, 2-40% B; 78-84 min, 40-90% B; 84-86 min, 
90% B; 86-87 min, 90-2% B; 87-95 min (column re-equilibration), 2% B.  A Thermo Q Exactive 
Plus Orbitrap mass spectrometer (Thermo Scientific, San Jose, CA, USA), equipped with a 
nanoelectrospray ionization source, was used to analyze the eluting peptides.  The instrument 
method consisted of MS1 using an MS AGC target value of 3x106, followed by up to 15 MS/MS 
scans of the most abundant ions detected in the preceding MS scan.  A maximum MS/MS ion 
accumulation time of 80 ms was used with a MS2 AGC target of 1x105 and an intensity threshold 
of 2.5x104.  Dynamic exclusion was set to 30s, HCD collision energy was set to 27 normalized 
collisional energy, and peptide match and isotope exclusion were enabled.  Peptides were 
identified using Protalizer (Vulcan Analytic, Birmingham, Alabama, USA) as described above. 
Top-Down Tandem-Mass Spectrometry 
 For top-down tandem mass spectrometry of the extractions not directly coupled to the LC 
from the three targeted regions of mouse pup, extracted proteins were diluted 5-fold in 0.1% formic 
acid and were loaded onto a reverse-phase capillary trap column using a helium-pressurized cell. 
The trap column (360 µm OD x 150 µm ID) was fritted with a filter end-fitting (IDEX Health & 
Science) and packed with 4 cm of C4 reverse phase material (Halo, 400 Å). An M-520 microfilter 
union (IDEX Health & Science) was used to connect the trap column to a capillary analytical 
column (360 µm OD x 100 µm ID), which was equipped with a laser-pulled emitter tip and packed 
with 15 cm of C4 material. Using an Eksigent NanoLC Ultra HPLC, proteins were gradient-eluted 
at a flow rate of 500 nL/min, and the mobile phase solvents consisted of 0.1% formic acid, 99.9% 
water (solvent A) and 0.1% formic acid, 99.9% acetonitrile (solvent B).  A 100-minute gradient 
was performed and eluted proteins were mass analyzed using an ETD-enabled LTQ Orbitrap Velos 
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mass spectrometer with a nanoelectrospray ionization source (Thermo Scientific, San Jose, CA, 
USA). The instrument was operated using a data-dependent method. A full scan spectrum of m/z 
400–2000 was acquired as the initial scan event per duty cycle. Following the full-scan, four data-
dependent scan events were performed using ETD in the linear ion trap for the four most abundant 
ions in each MS scan. Dynamic exclusion was enabled allowing a repeat count of 1 within 20 
seconds. ETD tandem mass spectra were acquired sequentially using the linear ion trap followed 
by the Orbitrap (resolving power 15,000 at m/z 400) for mass analysis. An isolation width of 3 m/z 
and an ETD reaction time of 90 ms were used for MS/MS analysis. The MSn AGC target value in 
the ion trap was set to 2x104, the MSn AGC target for Orbitrap scan events was 8 x105, and the 
ETD reagent ion (fluoranthene) AGC target was set to 1x105.  Protein Metrics Byonic (San Carlos, 
CA, USA) search engines were used to process the raw data against a rat protein database created 
from the UniprotKB protein database. Variable modifications including methionine oxidation, 
methylation, demethylation, and phosphorylation were used in the search and the false discovery 
rate was set to 1%. Database results were used to guide manual de novo sequencing. All proteins 
selected for de novo sequencing had Byonic identification scores >1,000.  
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CHAPTER IV 
 
MICROLESA: INTEGRATING AUTOFLUORESCENCE MICROSCOPY, IN SITU 
MICRO-DIGESTIONS, AND LIQUID EXTRACTION SURFACE ANALYSIS FOR 
HIGH SPATIAL RESOLUTION TARGETED PROTEOMIC STUDIES  
This chapter was adapted from the previous published Ryan et al., Analytical Chemistry, 
Copyright 2019 by ACS 
 
Overview 
The ability to target discrete features within tissue using liquid surface extractions enables 
the identification of proteins while maintaining the spatial integrity of the sample. Previous 
approaches employing a standard liquid micro-extract was limited to interrogate tissue foci on the 
order of 600 μm in diameter. In order to combat this limitation, a liquid extraction surface analysis 
(LESA) workflow, coined microLESA, was developed. This new workflow allows proteomic 
profiling from discrete tissue features (<150 μm in diameter) by integrating non-destructive 
autofluorescence microscopy and spatially targeted liquid micro-digestions with LESA. 
Autofluorescence microscopy provides the visualization of tissue foci without the need for 
chemical stains on the section of tissue or the use of serial tissue sections. Tryptic peptides are 
generated from tissue foci by applying picoliter (pL) droplets of enzyme onto the surface prior to 
LESA.  The microLESA workflow reduced the diameter of the sampled area almost 5-fold 
compared to previous LESA approaches. Experimental parameters were tested and optimized for 
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the enzymatic micro-digest, such as tissue thickness, trypsin concentration, and incubation 
duration. The microLESA workflow was applied to the study of fluorescently-labeled 
Staphylococcus aureus infected murine kidney in order to identify unique proteins related to host 
defense and bacterial pathogenesis. Proteins related to nutritional immunity and host immune 
response were identified by performing microLESA at the infectious foci and surrounding abscess. 
These identifications were then used to annotate specific proteins observed in infected kidney 
tissue by MALDI FT-ICR IMS through accurate mass matching. 
Introduction 
  The ability to determine the spatial distribution of a protein species, and their 
various proteoforms (e.g. post-translational modifications), in a tissue sample has proven useful in 
interrogating biological processes related to health and disease.59, 143, 175 In many cases, this is done 
using MALDI MS by either collecting individual spectra from discrete foci as a histology guided 
profiling experiment140, 176 or by imaging the tissue by rastering the sample to collect spectra at 
every pixel location.41, 149 However, identification of proteins directly from tissue using MALDI 
can be challenging due to reasons discussed in earlier chapters, such as fragmentation efficiency. 
Traditionally, homogenized tissue extractions have been used to compliment MALDI MS 
experiments and provide identifications.50, 177 These methods have proven to be effective and allow 
for relative and absolute quantification of the analytes extracted from tissue.178, 179 Although bulk 
homogenization of the sample maximizes analyte extraction, the process leads to a complete loss 
of the spatial information making identification of protein signals from distinct foci difficult.  
 Spatially targeted protein identification strategies have been developed that extract material 
from tissue surfaces using spatially targeted means to correlate proteomic identifications with 
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specific tissue foci observed in spatially targeted MALDI experiments. Proteomic profiling of 
discrete tissue foci has been accomplished using different approaches: tissue punch biopsies,180, 181 
laser capture microdissection (LCM),182-184 hydrogel extractions,74, 152 and liquid micro-
junctions.156, 157 LESA was shown earlier to be an effective, high-throughput approach for spatially 
targeted protein identifications.185 The LESA experiment utilizes small volumes of solvent (~0.5-
3.0 µL) that can be manipulated on the tissue section surface to extract analytes. A glass capillary 
delivers and dispenses the solvent on the tissue while maintaining a liquid micro-junction between 
the tip, liquid, and sample allowing for the extraction of endogenous molecules into the solvent. 
Following surface contact, the liquid can be aspirated off the sample and collected for off-line 
workflows or directly injected into a mass spectrometer for analysis. Although efficient, the LESA 
droplet diameter on tissue of approximately 500-600 μm and is the limiting factor in determining 
what foci can be interrogated. The ability to resolve small histological foci using MALDI has 
created the need to advance these complimentary molecular identification technologies to achieve 
similar spatial fidelity.  
 The deposition of small volume droplets (< 500 pL) of liquid (matrix or trypsin) is used 
routinely to profile discrete regions of tissue by MALDI MS.151 This type of droplet-based 
deposition has been demonstrated to enable MS analysis of these tissue areas. For trypsin droplet 
deposition experiments, MALDI is typically used for analysis but LESA has also been 
demonstrated to be effective for extracting peptides from areas digested using LESA-based 
approaches. Prior research combined droplet-based trypsin deposition with liquid micro-extraction 
to decrease the area of the region to be subjected to enzymatic digestion.186 This approach bypasses 
the typical limitations imposed by LESA (i.e. large extraction droplet diameter on tissue) by 
targeting tryptic peptides that are produced only in the tissue foci where the droplet-based micro-
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digest has been performed. Although this represents an improvement over traditional LESA 
workflows, further development is needed to improve spatial resolution and precision so that 
spatially targeted proteomics experiments can be performed on specific tissue substructures and 
cell types.  
 Staphylococcus aureus is a widely studied Gram-positive bacterium that is 
responsible for over 40,000 deaths annually.187, 188 S. aureus infections often lead to the generation 
of purulent, inflammatory foci known as an abscess. S. aureus infection and subsequent abscess 
formation is best described in 4 stages.189 Initially, the opportunistic bacteria enters the body and 
eventual peripheral tissue while circulating through the bloodstream. A lesion is induced and a 
chemotactic response initiates the massive migration of host immune cells such as neutrophils, 
leukocytes, and other phagocytes.190 The abscess begins to mature and grow in size, and present a 
central accumulation of pathogen. The regions surrounding the SAC are composed of necrotic 
tissue, a fibrin pseudocapsule, and a micro-colony associated meshwork.191   These surrounding 
regions of the abscess are dynamic in nature, with both the host and bacteria fighting for survival. 
For example, the host has evolved mechanisms to hamper bacterial growth by sequestering metal 
vital for the development and progression of S. aureus, a process known as nutritional immunity.192 
Finally, growing abscesses will rupture causing secondary infections through the spread of 
bacteria. It is this final stage of the abscess formation where the bacteria begin to infect new sites, 
and without antimicrobial intervention, the host often dies from the infection.189  
MALDI IMS has been applied to study the site of a S. aureus  infection, as it allows for the 
ex vivo analysis of key molecules involved in the infections progression, and their distribution to 
specific cellular areas.193 For example, using MALDI IMS the metal-chelating heterodimer 
calprotectin, consisting of the subunits S100A8 and S100A9, was found to localize to the site of 
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infection where it binds and removes metals which are essential to the bacteria’s growth and 
disease progression.139 The major hurdle in imaging proteins from the infectious foci is identifying 
the resulting peaks in the average mass spectrum. Commonly, orthogonal approaches such as tissue 
homogenization or LESA are used to gather spatially targeted identifications. Although useful, 
these approaches severely limit what foci can be targeted. Bacterial colonies are on the order of 
10-20 μm in diameter, and are very difficult to visualize through traditional microscopy without 
any prior histological staining.194, 195 Through the incorporation of fluorescently-labeled bacteria 
the user can better visualize these bacterial colonies at the site of infection, which would normally 
be difficult to target using AF alone due to a lack of contrast with the surrounding fluorescing 
regions of the abscess.196 Using the microLESA workflow and labeled bacteria, we can more 
accurately target these small colonies and the necrotic tissue surrounding them in order to get a 
better picture of the pathogenic progression as it is occurring in tissue.  
 Herein, we report a new workflow combining LESA with histology directed micro-
digestions on tissue targeting specific histological structures based on high resolution, non-
destructive AF microscopy. Autofluorescence (AF) microscopy has recently been demonstrated to 
improve accurate microscopy-IMS registration197 and histological targeting198 in MALDI IMS 
workflows. Tissue AF is the fluorescence of endogenous fluorophores in the tissue sample. AF 
microscopy is a high contrast, high resolution morphologically rich microscopy modality. Because 
AF does not require any tissue processing or staining and so does not modify the molecular make-
up of tissue allowing for downstream targeted molecular analysis. This enables histological 
determination of tissue regions-of-interest (ROI) to be defined on the same tissue section prior to 
spatially targeted proteomics, bypassing complicated registration procedures between serial tissue 
sections. A piezoelectric spotting system with a robotic stage was used for spotting micro-digestion 
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solutions after ROI identification on the AF image; a new workflow referred to as microLESA 
herein. Optimization of digestion sensitivity, trypsin concentration, digest spot size, and digestion 
time are all reported. The microLESA workflow was applied to study the host-pathogen interface 
in mouse kidney that was infected with Staphylococcus aureus. In this work we show advanced 
proteomic targeting of small histological structures (100 µm) guided by a non-destructive AF 
microscopy. 
Results 
The microLESA workflow, depicted in Figure 4.1, utilizes both autofluorescence 
microscopy and liquid micro-digestions in order to target discrete features on the tissue surface for 
enzymatic digestion. Once digested, peptides are extracted using a traditional LESA. In order to 
achieve a robust digest, experimental parameters such as trypsin concentration and tissue 
thickness, were optimized. 
  
Figure 4.1: Overview of microLESA workflow. 1A) Briefly, the tissue is sectioned and mounted 
onto a microscope slide. An autofluorescence microscopy image is acquired to identify foci for 
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trypsin spotting. Trypsin is dispensed onto the tissue surface and incubated at 37 °C. Digested 
peptides are then extracted from the tissue using a traditional LESA. 1B) The digested area on 
tissue is dictated by the area of the micro-digest of trypsin, represented by a solid red circle. The 
digested peptides are collected from tissue using a traditional LESA (purple circle) that is larger 
than the digested area (red circle).  
 
microLESA: Achievable Spatial Resolution 
To quantify this observation, a series of dispensing conditions were tested, varying the 
amount of drops dispensed in one annotated region. The results of this experiment are depicted in 
Figure 4.2. A trypsin solution (0.075 µg/µL) was deposited onto water sensitive paper while 
varying the number of drops during each dispense event. As shown in Figure 4.2, when a single 
220 pL drop was dispensed 21 separate times (60 s between droplets) the final trypsin spot on 
surface was ~112 µm (RSD 4.33%). It is noted that 21 drops was chosen to mimic the total volume 
of trypsin used for prior studies (~4.5 nL).199 This trypsin micro-digest spot size is 5x smaller than 
previously reported LESA spot size.185 An increase in trypsin spot diameter was observed as the 
number of droplets during a single dispensing event increased.  For example, when dispensing 7 
drops during a single event the trypsin spot increased ~95% in diameter (~220 µm, RSD 3.82%), 
as seen in Figure 4.2. Although the throughput of the spotting experiment is increased by 
dispensing more droplets at once, minimizing the droplet diameter was of greater importance for 
the remaining experiments, and a single drop per dispensing event was employed throughout the 
remainder of this study.  
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Figure 4.2: The measured droplet diameters (volume ~220 pL) of trypsin micro-digests from 
water-sensitive paper. The total amount of droplets dispensed at a single time was varied from 1 
to 7, while still varying the total number of dispension runs within a sample set to equate to the 
same total volume dispensed on a given spot (i.e. 1 spot dispensed 21 individual times yields the 
same total volume dispensed as 7 spots, dispensed 3 total times). Each run was completed 5 
separate times (N = 5) and bright field microscopy was used for measurement. 
 
Micro-digestion Trypsin Concentration and Digest Sensitivity 
To determine an optimal trypsin concentration for the micro-digest, varying trypsin concentrations 
(0.75, 7.5, and 75 ng/µL) were tested by digesting rat liver hepatocytes. Each concentration of 
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trypsin was tested in triplicate by dispensing single ~250 pL droplets until a total volume of 2.5 
nL was deposited, per digest spot. A rat liver tissue section was divided into 3 regions, one for 
each trypsin concentration. Tissue regions had 3 separate digest regions for technical replicates, 
each containing 3 individual micro-digest spots (depicted in Figure 4.3). LESA was used to extract 
peptides from each digest region. Bottom-up proteomics analysis of the digests with varying 
trypsin concentrations (0.75, 7.5, and 75 ng/µL) resulted in 61 ± 11 (RSD 17.3%), 308 ± 40 (RSD 
12.8%), and 614 ± 6 (RSD 0.9%) unique protein identifications respectively. Moving an order of 
magnitude in concentration, 75 down to 7.55 ng/µL, led to a ~50% loss in the total number of 
protein identifications, and thus the remaining experiments were completed with trypsin 
concentrations of 7.5 ng/ µL. Due to the volume of trypsin needed for the instrument to dispense, 
moving an order of magnitude higher to 750 ng/μL makes the experiment cost prohibitive.  
 
Figure 4.3: Optimization of trypsin concentration for microLESA digestion. A) A section of rat 
liver was divided into 3 regions. For each microLESA extract gathered (purple circle outline), 3 
separate dispensing’s of trypsin were deposited (red filled circle). Each concentration was tested 
in triplicate, extracting digested peptides from the 3 digested spots. B) The number of unique 
proteins identified as a function of trypsin concentration increased as the concentration increased. 
C) The spread between the protein identifications is depicted, with the majority of the proteins ID 
in the 0.75 and 7.5 ng/µL samples being identified in the 75 ng/µL samples. 
 
Aside from the concentration of trypsin deposited onto a tissue surface, varying the number of 
digest spots to be targeted by a single LESA will also affect the total protein counts (i.e. increasing 
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the number of digest spots within one traditional LESA spot). To evaluate the importance of this 
parameter, the number of digestion spots per LESA extract was varied from 1 to 5 (Figure 4.4). 
Digestion spots, each with a total volume of ~2.5 nL, were deposited onto rat liver hepatocytes for 
analysis. From a single digestion spot, 372 unique proteins were identified from the liver. This is 
of great importance to note, as not all tissue foci of interest will be located on the surface, in groups, 
for digestion. It is useful to know that a large number of proteins are identifiable, relative to the 
area interrogated, by digesting one single spot on tissue. The number of identifications scaled 
linearly (R2: 0.921, m: 88.1) to a total of 755 unique protein ID’s gathered from 5 digested areas, 
a 2-fold increase from the single digestion.  
 
Figure 4.4: The total number of unique proteins identified as a function of digest areas per LESA 
extract. Trypsin was deposited onto rat liver (total volume of ~2.5 nL per digest spot) and the total 
number of digest spots per LESA extraction area was increased from 1 to 5. 
 
Micro-Digestion Incubation Time and Tissue Thickness 
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The LESA extraction takes only a few minutes to complete and requires minimal sample 
preparation steps. The major factors limiting throughput in the microLESA experiment are the 
chromatography and the time allotted for the digestion to occur. To determine optimal trypsin spot 
incubation times, 12 µm sections of rat liver underwent the microLESA workflow using 30 
minutes, 1 hour, 2 hour, and 5 hour (incubation temperature: 37 °C) incubation times. Following 
digestion, two separate 2 µL LESA extracts of the peptides from each digest region were combined 
and subjected to offline LC-MS/MS. The 30 minute digestion produced 528 ± 99 (RSD 18.7%) 
unique protein identifications. This number was somewhat lower in the number of proteins 
identified as well as higher in variability between the sample sets than the other conditions. For 
example, 1 hour and 2 hour incubations resulted in 732 ± 8 (RSD 1.1%) and 714 ± 22 (RSD 3.1%) 
unique protein identifications respectively. The 5 hour time point was also high in variability, 
generating 568 ± 159 (RSD 27.9%) unique protein identifications. Because long digestion times 
did not yield a greater number of protein identifications 1-2 hour digestions were determined to be 
optimal for microLESA experiments. Tissue thickness was also tested by applying the microLESA 
workflow to extract peptides from rat liver tissue sections that varied in thickness from 8-30 μm. 
It was determined that the thickness of the tissue section has no effect on the number of proteins 
identified. The results from this experiment are displayed in Figure 4.5.  
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Figure 4.5: The tissue thickness as a function of unique proteins and peptides identified was 
studied using micro-digests combined with a LESA extract. Three digestion spots per extract were 
analyzed using LC-MS/MS. the results show there is no statistical change in the number of peptide 
and protein identifications between the sample sets (ANOVA: p-value 0.289 for peptides identified 
and p-value 0.0919 for unique proteins identified). These results suggest that the digestion may 
only be occurring on the surface of the tissue.  
 
Elucidating the Proteomic Drivers of Host-Pathogen Interactions 
As a proof-of-concept, kidney tissue from a mouse infected with GFP+ labeled S. aureus 
bacteria was subjected to the microLESA workflow and MALDI IMS. The fluorescence image 
(tissue autofluorescence and fluorescently labelled bacteria) of the kidney is depicted in Figure 
4.6. The autofluorescence signal makes evident the many abscesses present within the tissue 
(labeled, Figure 4.6). Because within this plane of the tissue the largest bacterial colonies were 
observed in the bottom abscess, this region was chosen for microLESA. Five ROIs were chosen 
for trypsin spotting covering both the bacterial colonies and surrounding necrotic regions within 
the abscess. Following incubation, LESA was performed three times to ensure all digested peptides 
were extracted for LC-MS/MS analysis resulting in ~2,700 unique protein identifications. Mouse 
immune response proteins were identified, such as neutrophil response factors like the S100A9 
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protein (Protein ID: P31725) which is known to localize to the abscess during infection to sequester 
Mn2+ and Zn2+.200 Also identified are neutrophil secretory proteins such as neutrophil elastase 
(Protein ID: Q3UP87), a serine protease responsible for killing bacteria but can be inhibited by 
serine protease inhibitors released from S. aureus during infection.201 Upwards of 65 unique S. 
aureus specific proteins were identified. Staphylococcal complement inhibitor (Protein ID: 
A6QIG6) is known to counteract the host immune response by reducing phagocytosis following 
opsonization and blocks all the downstream effector functions by selectively binding and 
inhibiting C3 convertases which play a role in the complement system activated during 
inflammation.202 Also identified from the colony digests is the protein Iron-regulated surface 
determinant protein B (IsdB, Protein ID: A6QG30). It is known that S. aureus needs iron in order 
to replicate and continue to grow, but the host immune response is primarily aimed at sequestering 
and removing all iron at the site of infection in order to limit growth and kill the invading 
pathogens. IsdB is part of the iron-regulated surface determinant system responsible for binding 
heme, bringing it through the cell wall and membrane of the bacteria where it can then be degraded 
to free iron to be used as a nutrition source for the bacteria.203 The identification of proteins 
involved in bacterial growth and survival directly from infected tissue is crucial in understanding 
the evolution and progression of a S. aureus infection. A list of selected S. aureus and neutrophil-
specific proteins identified from the abscess using the microLESA workflow are presented in Table 
4.1. 
Table 4.1: Unique protein identifications from the abscess of a S. aureus infected murine kidney. 
Proteins identified from the bacterial colonies present in the abscess are listed, as well as proteins 
secreted by neutrophils to fight the infection. Proteins were identified with at least 2 peptides per 
protein, with a false discovery rate of 1%. 
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Staphylococcus Aureus Protein Identifications 
|Q2FGF0| UPF0365 protein |Q2FFF8| Staphylococcal complement inhibitor 
|Q2FH00| Alanine dehydrogenase 1 
|Q2FFJ6| Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase 
subunit B 
|Q2FH01| L-threonine dehydratase catabolic TdcB |Q2FFQ5| Foldase protein PrsA 
|Q2FHG3| Ribonuclease J 2 |Q2FFV5| Phosphoenolpyruvate carboxykinase (ATP) 
|Q2FHG9| Translation initiation factor IF-2 |Q2FG18| 30S ribosomal protein S4 
|Q2FHI1| Elongation factor Ts |Q2FG27| Acetate kinase 
|Q2FHI2| 30S ribosomal protein S2 |Q2FG28| Putative universal stress protein 
|Q2FHI3| GTP-sensing transcriptional pleiotropic repressor CodY |Q2FG40| Pyruvate kinase 
|Q2FHR7| Carbamate kinase 1 |Q2FG54| Threonine--tRNA ligase 
|Q2FHS7| FPRL1 inhibitory protein |Q2FG61| Trigger factor 
|Q2FHT6| Thioredoxin |Q2FGD8| 30S ribosomal protein S20 
|Q2FHV1| Iron-regulated surface determinant protein A |Q2FGE3| Chaperone protein DnaK 
|Q2FHV2| Iron-regulated surface determinant protein B |Q2FJG3| Nucleoid-associated protein SAUSA300_0453 
|Q2FIB3| Glucose-6-phosphate isomerase |Q2FJN4| Alkyl hydroperoxide reductase C 
|Q2FIG2| UPF0337 protein SAUSA300_0816 |Q2FJP8| ribosomal protein S6 
|Q2FIK4| Extracellular matrix protein-binding protein emp |Q2FK15| Ribitol-5-phosphate cytidylyltransferase 1 
|Q2FIL7| Enolase |Q2FK29| L-lactate dehydrogenase 1 
|Q2FIS2| Lipoteichoic acid synthase |Q2FK44| Formate acetyltransferase 
|Q2FJ31| Alcohol dehydrogenase |Q2FK96| Heme oxygenase (staphylobilin-producing) 2 
|Q2FJ87| Uncharacterized epimerase/dehydratase SAUSA300_0538 |Q2FDQ4| Fructose-bisphosphate aldolase class 1 
|Q2FJ92| Elongation factor Tu |Q2FDQ7| L-lactate dehydrogenase 2 
S100 Protein Identifications 
|P31725| Protein S100-A9 |P97816| MOUSE Protein S100-G 
|P50543| Protein S100-A11 |P27005| Protein S100-A8 
|P07091| Protein S100-A4 |P97352| Protein S100-A13 
Neutrophil Protein Identifications 
|Q09014 |Neutrophil cytosol factor 1 |O70138| Neutrophil collagenase 
|O70145| Neutrophil cytosol factor 2 |P11672| Neutrophil gelatinase-associated lipocalin O 
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|O08692| Neutrophilic granule protein |P97369| Neutrophil cytosol factor 4 
|Q3UP87| Neutrophil elastase  
 
Protein identifications from microLESA extracts were used to annotate specific proteins observed 
in MALDI IMS data acquired from a serial section of S. aureus infected mouse kidney, 
demonstrating the utility of integrating microLESA into MALDI IMS workflows. Protein IMS 
was completed at 60 μm spatial resolution on a modified 15T FT-ICR MS (reduced source 
pressure: 950 mTorr). The resulting image consisted of protein distributions ranging from ~3-29 
kDa, with a number of signals localizing to the abscesses. Both S100A8 and S100A9, the proteins 
that non-covalently bind to form the heterodimer calprotectin, were found localized intensely to 
the abscess regions. MALDI FT-ICR IMS provided the mass accuracy necessary to determine that 
S100A9 is both acetylated and methylated (mass accuracy: 1.13 ppm). Calprotectin is a metal-
chelating host protein complex that accounts for an estimated 60% of the cytosolic protein content 
of neutrophils.204 Because bacteria require elemental nutrients for survival, metal sequestration is 
a primary mechanism for resisting bacterial pathogen proliferation within vertebrates, a process 
known as nutritional immunity.192, 205 
N-acetylated cytochrome C oxidase subunit 6C (Cox6c) was also identified by microLESA 
and observed by IMS. Cox6c is one of the subunits of the large cytochrome c oxidase complex 
that is part of oxidative phosphorylation in mitochondria.206, 207 The ability to identify proteins 
while maintaining spatial fidelity is critical for providing biological context to IMS results. 
MicroLESA provides a higher throughput, targeted approach to generate these identifications that 
when combined with IMS produce integrated data sets with both high spatial and molecular 
content.  
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Figure 4.6: Autofluorescence microscopy and MALDI IMS images of fluorescently-labeled S. 
aureus infected mouse kidney tissue. A) Autofluorescence microscopy images were acquired to 
visualize the abscess and bacterial colonies targeted for digestion. The interrogated abscess is 
circled in purple and a ‘zoomed-in’ capture highlights the colonies that were targeted for digestion 
(Red circles) using the microLESA workflow. B) MALDI FT-ICR IMS was used to investigate 
the distribution of intact proteins present in the tissue. Selected proteins are presented which were 
identified using the data collected from the microLESA experiment, correlating the identifications 
by accurate mass matching. 
 
 
Discussion 
 A new workflow, termed microLESA, is presented that allows for the proteomic analysis 
of discrete tissue foci. The new workflow incorporates autofluorescence microscopy to generate 
high resolution, non-destructive images that allow for the visualization of target features on the 
same section of tissue that will undergo digestion. The use of a Piezo electric spotter allows for 
the deposition of small volumes of liquid. Dispensing trypsin in a solution of ammonium 
bicarbonate, we were able to get a droplet diameter of approximately 110 μm, reproducibly. 
Analytical figures of merit for the microLESA workflow were also investigated. These 
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characteristics included: incubation duration, tissue thickness, and trypsin concentration. 
Autofluorescence enabled the gross morphology of the kidney tissue to be visualized, including 
abscesses and surrounding regions of a S. aureus infected murine kidney. S. aureus is unique as it 
can infect virtually any organ once it enters the bloodstream. The abscess architecture, although 
broadly defined, is still poorly understood in vivo. MALDI IMS enables the visualization of 
molecules vital for the host and pathogens survival; however, issues inherent to MALDI make 
their identification a challenge. As a case-study, we demonstrated the capabilities of this 
microLESA workflow to study abscess architecture. The resulting proteomics experiments 
produced thousands of protein identifications including a large number of bacterial proteins and 
proteins associated with host immune response. By integrating these data with imaging mass 
spectrometry, this workflow provides a way to effectively annotate species observed by MALDI 
IMS and delivers a more complete spatial proteomics description of a sample. 
 
Methods 
Micro-Digestions and Autofluorescence Microscopy 
For the microLESA experiments, trypsin was dissolved in a 12:88 v/v solution of acetic 
acid (100 mM) and ammonium bicarbonate (100 mM) to a final concentration of 75 ng/μL, except 
for the trypsin concentration optimization experiments (detailed in results section). A Piezoelectric 
spotting system (sciFLEXARRAYER S3, Princeton, NJ, USA) was utilized with a piezoelectric 
dispenser capillary nozzle (PDC 50, type 3) for trypsin deposition. For all experiments, either 
bright field or AF microscopy images were acquired (Eclipse 90i, Nikon Instruments Inc. Melville, 
NY, USA) prior to any spotting. For microLESA of S. aureus infected murine kidney, an AF image 
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was acquired prior to spotting using FITC and DAPI filters (FITC excitation λ: 465-495 nm, 
emission λ: 515-555 nm, and DAPI excitation λ: 340-380 nm, emission λ: 435-485 nm). All 
microscopy images were collected with either a 4 or 10x objective, generating images with a 
resolution of 2.29 and 0.92 µm/pixel, respectively. Microscopy exposure times were set to 200 ms 
for both filters. ROIs for trypsin spotting were annotated from a custom-built fiducial microscope 
slide, on microscopy images using ImageJ, and converted into relative coordinates for the 
piezoelectric spotter using an in-house developed Python script. The spotter was optimized to 
generate ~250 pL droplets while dispensing trypsin. Briefly, the spotting system uses a camera to 
recognize a point of origin on the sample for which to spot from. An arbitrarily chosen fiducial 
was utilized prior to any ROI generation and used as the origin for which all spots would deposited 
from. For all spotting runs, the piezo was initially tuned while dispensing pure water, then while 
dispensing a solution of trypsin, and in between all trypsin depositions to ensure a stable droplet. 
The PDC 50 was tuned to these approximate settings: 70-90 V, 40-60 µs, a frequency of 500 Hz, 
and an LED delay of 200 µs. These settings generated stable spot volumes of approximately 250 
pL using a PDC 50 nozzle with relative standard deviations under 10%. Following trypsin 
deposition, slides were incubated at 37 °C for 2 hours except for the incubation optimization 
experiments. 
Micro-Digestions: Spotting specific ROI’s with Trypsin 
In order to spot any liquid to specific ROI’s on a tissue section, a custom-designed fiducial slide 
was used to register the spotting system. Briefly, the spotting system uses a camera to recognize a 
point of origin on the sample for which to spot from. An arbitrarily chosen fiducial was utilized 
prior to any ROI generation and used as the origin for which all spots would deposited from. For 
all spotting runs, the piezo was initially tuned while dispensing pure water, then while dispensing 
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a solution of trypsin, and in between all trypsin depositions to ensure a stable droplet. The PDC 50 
was tuned to these approximate settings: 70-90 V, 40-60 µs, a frequency of 500 Hz, and an LED 
delay of 200 µs. These settings generated stable spot volumes of approximately 250 pL using a 
PDC 50 nozzle with relative standard deviations under 10%. 
Liquid Extraction Surface Analysis (LESA) 
Liquid surface extractions were completed using a TriVersa NanoMate (Advion Inc., 
Ithaca, NY, USA) with the LESAplusLC modification. Images of digested tissue were scanned 
using a flatbed scanner, uploaded, and annotated using the Advion ChipSoft software. LESA was 
performed by aspirating 5 µL of extraction solvent (2:8 acetonitrile:water, with 0.1% formic acid)  
into the glass capillary. The capillary was then lowered to a height of approximately 0.5 mm above 
the tissue surface, and 2.5 µL of solvent was dispensed onto the tissue surface. The liquid junction 
was maintained for 10 seconds and a volume of 3.0 µL was re-aspirated back into the capillary. 
The initially drawn 5 µL volume was then dispensed into a 96-well plate containing 200 µL of 
water/0.1% formic acid. For each digested ROI, two LESA extracts were gathered from the region 
and combined. To prevent sample carryover, three wash cycles were completed between each ROI 
set. All extracts were dried down under vacuum and stored at -80 °C until LC-MS/MS analysis. 
Control and blank samples were gathered from undigested rat liver and a plain glass slide to 
account for endogenous peptides present, prior to digestion. 
Animals and Bacterial Strains 
To create a stable GFP+ strain of S. aureus for subsequent murine infections and 
fluorescence microscopy, the region containing the sarA promoter driving sfGFP was first 
amplified out of pCM11 using primers 5’-
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GTTGTTTCTAGACTGATATTTTTGACTAAACCAAATG-3’ and 5’-
GTTGTTGAGCTCTTAGTGGTGGTGGTG-3’ (restriction sites underlined). The resulting PCR 
amplification product was then ligated into the XbaI and SacI site of pJC1111208 to create pNP1. 
pNP1 was then chromosomally integrated into the SaPI1 site of S. aureus as previously 
described.209 The region encompassing the chromosomal SaPI1 integration was then transduced 
into S. aureus strain LAC (AH1263) using phi80a. Integration of PsarA_sfGFP at the SaPI1 site 
was confirmed using primers JCO717 and 719.209 Frozen rat liver was purchased from Pel-Freeze 
Biologicals (Rogers, AR, USA), and stored at -80 °C until sectioning. All in-house animal 
experiments were performed with approval by the Vanderbilt Institutional Animal Care and Use 
Committee. Six to eight-week old female C57BL6/J mice were anesthetized with isoflurane and 
retro-orbitally infected with 3.6 x 107 colony forming units (CFUs) of Staphylococcus aureus LAC 
carrying a genomic sfGFP reporter under control of the sarA promoter. Mice were humanely 
sacrificed at 10 days post infection (DPI). Kidneys for imaging and microLESA experiments were 
aseptically removed and frozen on dry ice. 
MALDI IMS of Proteins 
MALDI IMS of proteins was performed on a modified Bruker SolariX 15T Fourier transform ion 
cyclotron resonance (FT-ICR) mass spectrometer (Bruker Daltonics, Billerica, MA, USA). The 
source pressure of the instrument was decreased to 950 mTorr to maximize the transmission 
efficiency of larger intact protein species by regulating the gas flow through the ESI port. Tissue 
preparation strategies and instrumental parameters are discussed in the supplemental information. 
In all experiments except the tissue thickness optimization, tissue was sectioned (12 µm thickness) 
at -15 °C using a CryoStarTM NX70 Cryostat (Thermo Fisher Scientific, San Jose, CA, USA), 
thaw mounted onto conductive indium-tin-oxide coated slides with custom printed fiducials in 
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black ink (Delta Technologies, Loveland, CO, USA)), and dried in a vacuum desiccator for at least 
20 minutes prior to preparation for analysis. Tissue sections underwent a washing prior to any 
imaging, micro-digestion, or surface extraction to remove interfering lipids and salts. The wash 
steps were as follows: 70% ethanol (30s), 100% ethanol (30s), Carnoy’s Wash (6:3:1 
ethanol:chloroform:acetic acid), 100% ethanol (30s), water (30s), and 100% ethanol (30s) as 
described previously.52  
For intact protein IMS, tissue was covered homogenously with DHA using a robotic 
sprayer (TM Sprayer, HTX Technologies, Carrboro, NC, US) at a concentration of 15 mg/mL in 
9:1, ACN:H2O (0.1% formic acid). The sprayer nozzle was set to spray at 85 °C using a carrier 
solvent of 9:1 ACN:H2O at a flow rate of 0.1 mL/min and a drying sheath gas of dry nitrogen set 
to 10 psi. Four passes of matrix were applied using alternating offsets (1 mm) and directional 
rotations (90 degrees) with a 2 mm track spacing. The spray velocity was set to 700 mm/min with 
a 2 s dry time between passes and 40 mm nozzle height. The matrix layer on the sample was 
recrystallized prior to MALDI analysis as previously described using 1.0 mL of 1:1, TFA:H2O at 
37 °C for 3 minutes. The image was acquired in positive ion mode at 60 µm spatial resolution on 
a 15T FT-ICR MS. The instrument employs a Smartbeam II 2 kHz frequency tripled Nd:YAG 
(355 nm) laser, as well as an Apollo II dual MALDI/ESI ion source. Each pixel was the sum of 
2000 laser shots, using the smallest laser focus (~50 µm), while random-walking the target within 
the 125 µm pixel. The mass spectrometer was externally calibrated prior to analysis using a protein 
mixture (insulin, cytochrome C, trypsinogen, and apomyoglobin). Data were collected from m/z 
1,385 - 20,000 with a time-domain file size of 512K (FID length: 1.6078 s), yielding a resolving 
power of ~42,000 at m/z 5000. In order to generate an image with a higher mass range, the ion 
optics were tuned as follows: accumulation hexapole (1.4 MHz, 1700 Vpp), time-of-flight delay 
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(2.1 ms), funnel RF amplitude (200 Vpp), transfer optics (2 MHz, 380 Vpp), and ICR cell (sweep 
excitation power: 40%). The source pressure was lowered to 950 mTorr in order to maximize the 
transmission of heavier species. 
Bottom-Up LC-MS/MS and Data Analysis 
For the microLESA optimization experiments, an analytical column was packed with 22 cm of 
C18 reverse phase material (Jupiter, 3 μm beads, 300Å, Phenomenox) directly into a laser-pulled 
emitter tip (Sutter Instrument Company, Novato, CA, USA).  Peptides were loaded on the capillary 
reverse phase analytical column (360 μm O.D. x 100 μm I.D.) using a Dionex Ultimate 3000 
nanoLC and autosampler.  The mobile phase solvents consisted of 0.1% formic acid, 99.9% water 
(solvent A) and 0.1% formic acid, 99.9% acetonitrile (solvent B).  Peptides were eluted with a 
gradient at a flow rate of 400 nL/min.  A 60-minute gradient was performed as follows: 1-2 min, 
2% B (sample loading from autosampler); 2-44 min, 2-35% B; 44-49 min, 35-95% B; 49-49.5 
min, 95% B; 49.5-50 min, 95-2% B; 50-60 min (column re-equilibration), 2% B.  A Thermo Q 
Exactive Plus Orbitrap mass spectrometer (Thermo Scientific, San Jose, CA, USA), equipped with 
a nanoelectrospray ionization source, was used to analyze the eluting peptides.  The instrument 
method consisted of MS1 using an MS AGC target value of 3x106, followed by up to 15 MS/MS 
scans of the most abundant ions detected in the preceding MS scan.  A maximum MS/MS ion 
accumulation time of 60 ms was used with a MS2 AGC target of 1x105 and an intensity threshold 
of 5x104.  Dynamic exclusion was set to 10s, HCD collision energy was set to 27 normalized 
collisional energy, and peptide match and isotope exclusion were enabled.  
For the microLESA experiments targeting the abscess in mouse infected with S. aureus, tryptic 
peptides from the tissue extracts were injected and gradient eluted on a pulled tip emitter column 
(360 μm O.D. x 100 μm I.D. x 35 cm) packed in-house with C18 material (Waters BEH C18, 1.7 
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μm, 130 Å). The column was heated to 60 °C with a flow rate of 400 nL/min during operation 
using an Easy-nLC 1000 UHPLC (Thermo Scientific, San Jose, CA, USA), where the mobile 
phase A consisted of 0.1% formic acid, 99.9% water, and mobile phase B consisted of 0.1% formic 
acid, 99.9% acetonitrile. Peptides were eluted on the reverse phase column using a linear gradient 
of 2-20% B for 100 minutes, followed by 20-32% B for 20 minutes, and lastly 32-95% B for 1 
minute. An Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific, San Jose, CA, USA) 
was used to mass analyze the eluting peptides. MS1 scans were acquired using the Orbitrap at 
120k resolution, a mass range of 400-1600 m/z, an automatic gain control (AGC) target of 1.0x106, 
and a maximum injection time of 100 ms. The top 17 most abundant ions measured in the MS1 
scans were then mass isolated using a quadrupole mass filter at 2 m/z window width to undergo 
fragmentation in the HCD cell using 35% normalized collision energy. The fragmented ions are 
subsequently mass analyzed in the linear ion trap using an AGC target of 1x104, a maximum 
injection time of 35 ms, and the normal scanning rate setting. Dynamic exclusion of 30 s was used 
for all MS2 scans. For identification of peptides from both instruments, tandem mass spectra were 
searched using Protalizer software (Vulcan Analytic, Birmingham, Alabama, USA) against a rat 
database created from the UniprotKB protein database (www.uniprot.org). Variable modifications 
such as acetylation, phosphorylation, methionine oxidation, and deamidation were included in the 
database search. Proteins were identified with at least 2 unique peptides per protein, with a false 
discovery rate of 1%. 
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CHAPTER V 
CONSPECTUS 
 
Overview 
 The development of next-generation, spatially targeted proteomic strategies has greatly 
improved the way in which we elucidate proteomic information from a tissue and has improved 
our identification strategies in MALDI IMS workflows. In the work detailed herein, both 
instrumental modifications and new sample preparation technologies were developed and 
implemented for protein analysis from tissue. First, protein ion transmission for high-performance 
MALDI IMS platforms was improved by optimizing the source pressure to maximize the effective 
potential wall confining ions through the first stage of a 15T FT-ICR MS. Additionally, the new 
spatially targeted surface sampling technology LESA was optimized and incorporated to 
complement MALDI IMS workflows to enable a high throughput approach to generate protein 
identifications from tissue incorporating top down or bottom up mass spectrometry. This 
technology was determined to be robust with regards to analytical figures of merit, but the standard 
LESA workflow is limited with regards to resolution, and is inadequate when studying foci smaller 
than 500 μm. To overcome the challenges associated with a traditional LESA (i.e. large droplet 
diameter on tissue), a new method incorporating an enzymatic micro-digestion was developed. 
This new approach was applied to study the host/pathogen interface of a staphylococcus aureus 
infection. In this conspectus, the current state of the field as it relates to these technologies is 
discussed. 
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Protein Ion Transmission in MALDI MS/IMS 
 MALDI IMS is continuing to grow with regards to applied research and technological 
development. For example, the development of high frequency lasers has generated instruments 
capable of acquiring tens of spectra per second.41 The continued development of mass 
spectrometers with improved mass resolution and mass accuracy has driven the technologies 
popularity and IMS is now routinely utilized to study a number of different diseases such as cancers 
and diabetes.24, 177, 193, 210 The proteome provides a unique environment to study which often 
reflects disruptions in health and the current state of a disease in a particular animal, and thus is a 
vital area for MALDI IMS. In order for the field to move forward and continue growing, challenges 
inherent to protein identification must be addressed. One of the limiting factors in protein MALDI 
MS, aside from fragmentation efficiency, is limited ion transmission within the mass spectrometer. 
Time-of-flight (TOF) mass spectrometers provide the greatest transmission range, relative to other 
mass spectrometers used in MALDI MS, and can routinely transmit and detect proteins beyond 35  
kDa from tissue.145 Although useful, these platforms lack the resolution necessary to isotopically 
resolve a protein distribution, and have limited mass accuracy making identification a challenge.  
In work discussed in Chapter 2, a commercially available FT-ICR MS instruments are 
capable of transmitting and detecting protein ions up to ~12-14 kDa.40 In order to increase the 
transmission range on this platform, the pressure region where the ion funnel is located (i.e. where 
ions are generated and initially transmitted) was regulated by modifying the ESI capillary to 
include the addition of a metering valve, as well isolation valves on the manifold pumping down 
the source region, and second rough pump to decrease pressure further, as highlighted in Chapter 
2. A number of experimental parameters were tested and optimized, such as the effect of off-axis 
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gas flow on ion transmission. It was found that raising the capillary to its highest setting (i.e. out 
of the way of the MALDI plume) provided the lowest interference with the ions being generated. 
Chapter 2 also reviews the effects of systematically decreasing the pressure in the source region. 
Moving from the ‘normal’ operating pressure of 2.9 Torr, to a reduced 750 mTorr, generated an 
increase in protein ion abundance by 10 to 100 fold. This pronounced effect was attributed to a 
less dampened effective potential for ion radial confinement and enabled the detection of protein 
ions up to m/z 24,000. Although the modifications have almost doubled our effective transmittable 
mass range, we are just beginning to push the envelope with regards to detecting average sized 
proteins found within a cell (i.e. mass > 35,000 Da), and an even greater increase in transmission 
will be needed to study the majority of the proteome. For example, yeast proteins are on average 
466 amino acids long, corresponding to an average mass of 53 kDa.211 Future work should focus 
around new instrumental modifications in the form of improved electronics. For example, RF 
generators capable of operating at lower frequencies are necessary for a higher mass transmission 
and could be introduced to enhance m.z sensitivity even further. Such research would enable a 
deeper study of the proteome by IMS and will be necessary to understand proteomic changes 
associated with disease. 
Protein Identification Using LESA 
Protein identification in MALDI IMS is crucial in helping to understand the physiological 
role of biomolecular and cellular systems. Prior to the development of LESA, orthogonal 
approaches utilizing a tissue homogenate were most commonly employed to generate protein 
identifications for MALDI IMS workflows. Although this approach can generate thousands of 
protein IDs, this technique relies on a complete pulverization of tissue, losing the spatial integrity 
gained during an IMS acquisition. The optimization of LESA, highlighted in chapter 3, enables a 
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new high throughput approach to identifications from tissue. By dispensing and aspirating a small 
volume of liquid (0.5-2.0 μL), the user can extract peptides and proteins from tissue foci as small 
as 600 μm in diameter. The LESA technology was first benchmarked with regards to analytical 
figures of merit, determining and optimizing such characteristics as sensitivity and resolution. The 
reproducibility of a robotic LESA extract was also examined, and it was found to be very 
reproducible with low RSD’s (< 5%). One of the unique characteristics inherent to the liquid 
extraction is the rate at which it can be completed. The entire experiment involves an in situ 
enzymatic digestion, extraction, and chromatography/mass spectrometry. In total, one can generate 
thousands of protein identifications in as little as 16 hours, if digesting the tissue overnight, and a 
single in situ tissue digest provides countless LESA extracts. Similar spatially targeted approaches, 
such as a hydrogel extraction, require almost twice that amount of time.74 The aforementioned 
experiment requires ~16 hr to cast a gel, ~1-2 hr for gel placement, ~14 hr for digestion, ~1-2 hr 
for peptide extraction, and ~1-2 hr for LC-MS/MS. In order to bypass the sample handling stages 
of a LESA, and gain an even greater increase in throughput, online HPLC was incorporated into 
the workflow. The new LESAplusLC experiment enables an all-in-one platform that is capable of 
extracting analytes and moving them onto an HPLC column for LC-MS analysis.  
The LESA technology is also capable of being applied to both top-down and bottom-up 
MS studies, extending its applications to enhance our current MALDI protein IMS workflows. 
Extracting from whole body mouse pup in Chapter 3, LESA extracts were subjected to top-down 
mass spectrometry on an Orbitrap MS. The spectra were sequenced de novo, and select 
identifications were mapped back to an intact MALDI IMS data set collected from the same animal 
demonstrating its utility in aiding in protein ID in a MALDI IMS workflow. Due to these 
advantages of the LESA experiment, a number of labs are employing this technology to generate 
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molecular information from a number of substrates including food, paper,158 and animals.212, 213 
Although this work advanced the applicability of LESA in IMS workflows, further work was 
needed to overcome the limited droplet diameter achievable on tissue.  
microLESA and the Host/Pathogen Interface 
Spatially targeted proteomic experiments are a powerful approach that allow one to place 
an ID with a region on tissue, and limitations in droplet diameter restrict what tissue foci can be 
analyzed using a standard LESA. Micro-spotting has proven to be useful approach to spot both 
enzyme and matrix for MALDI MS studies.151 Previous research utilized a micro-digestion to 
deposit small volumes of enzyme to reduce the dimension of analysis (i.e. digestion area on tissue) 
for bottom-up LESA extractions.186 Here, regions for micro-spotting were defined using MALDI 
IMS data and proteins were identified from regions as small as 250 μm.  In Chapter 4, a new 
workflow coined microLESA that incorporates both micro-enzymatic digestions and 
autofluorescence microscopy, was developed. MicroLESA allows for the reduction of the 
digestion area on tissue for a proteomic LESA analysis by incorporating liquid micro-spotting. 
Here, we are repeatedly dispensing a small (~260 pL) volume of trypsin on tissue, one drop at a 
time, which translates to a digestion spot of approximately 110 μm in diameter on the surface of 
the sample. The use of a droplet-based digestion improves the resolution of the digested area, 
forgoing the robotically sprayed, in situ digest used in Chapter 3. Following an incubation period, 
tryptic peptides are collected using a standard LESA, ensuring the area of digestion is covered 
with the liquid extract. Endogenous peptides are accounted for by completing a control extract 
from a non-digested region of tissue. One of the greatest challenges in developing the new 
workflow focused on finding a non-destructive approach to visualize target foci for micro-spotting. 
Prior research incorporating MALDI IMS relied on a serial section of tissue for proteomic analysis, 
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and often tissue substructures are lost due to the extra sectioning required for this. The use of 
autofluorescence (AF) microscopy enables the generation of a non-destructive, high resolution, 
high contrast image to visualize tissue morphology, forgoing the need for additional serial sections 
of tissue for the digestion. In our work, this allowed for the clear visualization of the substructure 
present within a staphylococcus aureus infected mouse kidney. The incorporation of fluorescently 
labeled bacteria enables the visualization of the bacterial colonies, ex vivo, and allows the user to 
target these foci for micro-digestion. microLESA analysis of the infectious foci present in the 
kidney yielded thousands of protein identifications and many related to host-defense responses.  
Outlook and Continued Development of Targeted Proteomic Technologies 
Modifications to a 15T FT-ICR MS have effectively doubled the transmittable mass range 
for routine MALDI IMS of proteins from a tissue section. Although we are currently detecting 
protein ions at twice the mass that was previously achievable, we are still only beginning to detect 
a small amount of all of the possible proteoforms present within a cell. Future work needs to entail 
the use of RF generators that allow the ion funnel to operate at lower frequencies in order to 
continue to push the boundaries of high mass transmission. Currently, the funnel does not allow 
for the tuning of the RF operating frequency, and only the magnitude of the applied RF can be 
varied. Future work should also incorporate the analysis of different biomolecular classes from 
tissue, including small molecule metabolites, lipids, and peptides.  
 Liquid extraction surface analysis, coupled to mass spectrometry (both online and 
offline) has greatly improved the way that we generate complimentary information for MALDI 
IMS of proteins. One of the greatest challenges facing protein identification in MALDI IMS, 
utilizing electrospray ionization-based experiments to generate IDs, is the poor overlap of the 
ionized species detected between ESI and MALDI. Currently, only 10-30% of protein ions 
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detected and identified utilizing ESI are detected in MALDI IMS experiments, severely limiting 
the number of IDs one can generate from tissue. In order to overcome this challenge and generate 
more informative information from tissue, in situ enzymatic digestions enabling a robust peptide 
MALDI IMS must be optimized. MALDI IMS of peptides allows for the detection of species of 
the same biomolecular class (i.e. peptides) that we are identifying in our LESA and microLESA 
experiments, enabling a direct comparison of the two experiments and a greater probability for 
making a molecular identification based on peptide identifications. Current challenges facing 
MALDI IMS of peptides are trypsin application, trypsin activity, delocalization of species after 
trypsin application, and limited throughput when generating tandem mass spectra for 
identification. 
MicroLESA has greatly improved the resolution of a bottom-up LESA experiment by 
incorporating both micro-digestions and autofluorescence microscopy. Currently, the technology 
is only being used to generate molecular identifications and no quantitative information is drawn 
from the resulting data. In order for this technology to improve and continue to grow, quantitation 
of the species being identified is critical and is the next step in the development of this approach. 
More often than not, proteins are expressed at increased or decreased levels during the progression 
of various diseases, and microLESA faces a number of challenges when trying to asses this metric. 
The digestion itself is quite variable, and the reliability of the data collected relies heavily on how 
stable the liquid droplet deposition is. The stability of the droplet is dictated by the solution of 
liquid, the analyte being dispensed, and the applied voltage and frequency to the Piezo nozzle. 
Dissolving trypsin in pure water enabled a stable droplet for our work. A number of approaches 
could be utilized for a more quantitative microLESA experiment. For example, acquiring data 
from a greater number of biological replicates enable one to analyze trends within the data, 
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focusing on abundant proteins that are always present within the extracts and their repective 
abundances (i.e. increased or decreased abundance) across different disease states.  
Conclusions 
Advancements in MALDI IMS instrumentation and spatially targeted proteomic 
technologies have enabled new and improved approaches to generate proteomic information from 
a tissue sample. To fully elucidate the underlying biology that these images represent, it is 
important to employ methods for the identification of protein signals afforded from IMS 
experiments. Recent developments in orthogonal, spatially targeted proteomics technologies and 
methods have allowed for more robust identification of peptides and proteins, driving the 
continued use of protein IMS towards next-generation biological applications. There is a focus in 
the field towards combining technologies to maximize sensitivity and fragmentation efficiency at 
higher spatial resolutions. For example, instrument source modifications to allow for finer control 
over source pressure are improving sensitivity of intact protein analysis on high-performance 
imaging platforms. Additionally, the implementation of charge state independent ion activation 
techniques, such as ultraviolet photodissociation, may hold the key to allowing spatially targeted 
fragmentation of intact proteins directly from tissue using MALDI. The field of spatially targeted 
proteomics would benefit greatly from the integration of these technologies into the IMS 
workflow, and would enable a visualization of a greater fraction of the proteome and ultimately a 
better understanding of pathologically relevant processes. This will usher in a new era of systems 
biology by providing spatial contextualization of the dynamic molecular interactions and protein 
networks found in intact tissues, opening new possibilities for probing disease-perturbed systems 
and drug target discovery. 
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 Vanderbilt University, Nashville, Tennessee 
 Advisor: Professor Richard M. Caprioli. Jeffrey M. Spraggins 
Bachelor of Science, Chemistry, Minors: Mathematics, Honors: Summa Cum Laude                           2011 – May 2015 
 University of North Carolina at Charlotte, Charlotte, North Carolina 
 Advisor: Professor Brian T. Cooper 
 
 
PUBLICATIONS  
 
5.  Daniel J. Ryan, Nathan H. Patterson, Nicole E. Putnam, Aimee D. Wilde, James E. Cassat, Eric P. Skaar, Richard M. Caprioli, 
Jeffrey M. Spraggins. MicroLESA: Integrating Autofluorescence Microscopy, In Situ Micro-Digestions, and Liquid Extraction 
Surface Analysis for High Spatial Resolution Targeted Proteomic Studies. Anal. Chem. 2019. 
4.  Eric C. Spivey, Josiah C. McMillen, Daniel J. Ryan, Jeffrey M. Spraggins, Richard M. Caprioli. Combining MALDI-2 and 
Transmission Geometry Laser Optics to Achieve High Sensitivity for Ultra-High Spatial Resolution Surface Analysis, J. Mass 
Spectrom. 2019, 54: 366-370. 
3.  Daniel J. Ryan; Jeffrey M. Spraggins; Richard M. Caprioli. Protein Identifications in MALDI Imaging Mass Spectrometry: A 
Review, Curr. Opin. Chem. Biol. 2018, 48: 64-72. 
2.  Boone M. Prentice; Daniel J. Ryan; Raf Van de Plas; Richard M. Caprioli; Jeffrey M. Spraggins. Enhanced Ion Transmission 
Efficiency of Proteins up to m/z 22,000 on a 15T FT-ICR MS for MALDI Imaging Applications. Anal. Chem. 2018, 90, 5090-
5099.  
1.  Daniel J. Ryan, David Nei, Boone M. Prentice, Kristie L. Rose, Richard M. Caprioli, Jeffrey M. Spraggins. Protein identification 
in imaging mass spectrometry through spatially targeted liquid micro‐extractions. Rapid Commun. Mass Spectrom. 2018, 32; 442-
450.  
 
PRESENTATIONS (presenter underlined) 
 
12. Daniel J. Ryan, Heath N. Patterson, James E. Cassar, Eric P. Skarr, Richard M. Caprioli, Jeffrey M. Spraggins “Analysis of 
Staphylococcus aureus Infections through Spatially Targeted Micro-Proteomics” 67th ASMS Conference on Mass Spectrometry & 
Allied Topics, Atlanta, GA, June 2019. 
11. Daniel J. Ryan, Heath N. Patterson, Jeffrey M. Spraggins, Richard M. Caprioli, “microLESA: Combining Fluorescence-Guided, 
Micro-Digestions with Liquid Surface Extractions” Chemical Biology Association of Students Monthly Seminar Series, Nashville, 
TN, May 2019. 
10. Daniel J. Ryan, Heath N. Patterson, Jeffrey M. Spraggins, Richard M. Caprioli, “Advanced Surface Sampling Technologies: 
Combining Fluorescence-Guided, Micro-Digestions with Liquid Surface Extractions” International Mass Spectrometry 
Conference, Florence, Italy, August 2018. 
9. Boone M Prentice; Daniel J. Ryan; Raf Van de Plas; Jeffrey M. Spraggins; Richard M. Caprioli, “Enhanced ion funnel 
transmission efficiency up to m/z 24,000 for MALDI FT-ICR protein imaging mass spectrometry”. 66th ASMS Conference on MS 
& Allied Topics, San Diego, CA, June 2018. 
8.  Daniel J. Ryan, Jeffrey M. Spraggins, Boone M. Prentice, Richard M. Caprioli, “High Spatial Resolution MALDI IMS on a 9.4T 
FTICR Through the Addition of a Second Laser Enabling Simplistic Beam Alignment and Dual Modes of Operation” Imaging 
Mass Spectrometry Society Inaugural Conference, Boston, MA, October 2017. 
7.  Daniel J. Ryan, David Nei, Boone M. Prentice, Jeffrey M. Spraggins, Richard M. Caprioli, “Linking Protein Identifications to 
Imaging Mass Spectrometry through Spatially Resolved Proteomics” AbbVie Analytical Research Symposium, Chicago, IL, 
August 2017. 
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6.  Daniel J. Ryan, David Nei, Boone M. Prentice, Jeffrey M. Spraggins, Richard M. Caprioli, “Spatially Resolved Proteomics to 
Improve Protein Identification in Imaging Mass Spectrometry” Vanderbilt Institute of Chemical Biology Symposium, Nashville, 
TN, August 2017. 
5.  Daniel J. Ryan, David Nei, Boone M. Prentice, Jeffrey M. Spraggins, Richard M. Caprioli, “Histology Directed Liquid Surface 
Extractions coupled Directly to Liquid Chromatography for Improving Identification Strategies in Advanced IMS Applications” 
65th ASMS Conference on MS & Allied Topics, Indianapolis, IN, June 2017. 
4.  Jeffrey M. Spraggins, Raf Van de Plas, Jessica L. Moore, Daniel J. Ryan, Richard M. Caprioli, “Maximizing performance of 
spatial proteomics through the fusion of ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR IMS,” 64th ASMS 
Conference on MS & Allied Topics, San Antonio, TX, June 2016. 
3.  Daniel J. Ryan, Boone M. Prentice, Raf Van de Plas, Jeffrey M. Spraggins, Richard M. Caprioli, “Histology-Directed Lipid 
Identification: Advanced Imaging Mass Spectrometry and Liquid Extraction Technologies Enable Spatially Specific Tandem Mass 
Spectrometry” 64th ASMS Conference on MS & Allied Topics, San Antonio, TX, June 2016. 
2.  Daniel J. Ryan, Brittany Gray, Daniel Rabinovich, “Expanding the Octet: A look into Hypervalent Compounds,” 2013 University 
of North Carolina Charlotte Undergraduate Research Conference, Charlotte, NC, June 2013.  
1.  Daniel J. Ryan, Brittany Gray, Daniel Rabinovich, “Synthesis of New Hypervalent Compounds,” State of North Carolina 
Undergraduate Research and Creativity Symposium, Duke University, Durham, NC, May 2012. 
 
HONORS, AWARDS, & FUNDING 
 
2019 Warren Fellowship                 Summer 2019 
2018 Journal of Mass Spectrometry Symposium Award                Spring 2018 
Vanderbilt Institute of Chemical Biology Fellowship                 Fall 2015 – Spring 2016 
Suma cum laude, BS Chemistry                                     Spring 2015    
Dean’s list              Fall 2011 – Spring 2015 
 
LABORATORY EXPERIENCE  
 
Graduate Dissertation Research (Vanderbilt University, Dept. of Biochemistry)         2015 - present 
o Research emphasizing the fundamental development and technological advancements of protein identification for 
imaging mass spectrometry (IMS) under the direction of Professor Richard M. Caprioli  
• Optimized and incorporated the use of enhanced robotic liquid surface extractions to aid in protein identification 
strategies in MALDI IMS experiments through the use of online LC-MS, top-down, and bottom-up mass 
spectrometry. 
• Developed a new targeted proteomic workflow coined ‘microLESA’ by combining autofluorescence microscopy 
and robotic, micro-enzymatic digestions to target tissue foci on the order of ~120 μm for digestion and mass 
spectrometry analysis. 
• Designed the addition and implementation of a second, high speed laser to improve spatial resolution in FTICR 
MALDI IMS to <10 μm.  
• Enhanced protein ion transmission on a 15T FT-ICR mass spectrometer by modifying the source region in order to 
optimize the pressure and improve transmission efficiency, allowing for the detection of species up to m/z 22,000 
Da.  
Undergraduate Research (University of North Carolina at Charlotte, Dept. of Chemistry)      Fall 2013 - Spring 2015 
o Establishing methods of derivatization to test the accuracy of the new metabolomics deconvolution  
software ADAP 2.0 through the use of GC-MS under the supervision of Dr. Brian Cooper. 
Undergraduate Research (University of North Carolina at Charlotte, Dept. of Chemistry)      Fall 2012 - Spring 2013 
o Synthesis and reactivity of a new bis(picolyl)selone ligand, including the preparation of silver(I)  
      complexes and hypervalent halogen (Br2, I2) derivatives 
 
TECHNICAL EXPERTISE 
Instrumentation Utilities/Software 
o Extensive experience in troubleshooting and fixing a variety of instruments on several 
platforms 
o Microsoft Office 
o PowerPoint 
• 15T FT-ICR MS (Bruker Solarix) o SIMION 
• 9.4T FT-ICR MS (Bruker SolariX) o Autodesk Inventor 
• MALDI TOF MS (Bruker RapiFlex) o flexImaging, flexControl 
• Orbitrap Elite (Thermo Velos Pro) 
• TriVersa NanoMate Surface Sampler (Advion) 
• scieFLEXARRAYER Liquid Dispenser (Scienion AG) 
o Xcalibur 
o PMi Byonic 
o Bruker Data Analysis 
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TEACHING & MENTORING EXPERIENCE 
 
Workshop Assistant (Vanderbilt University, Department of Biochemistry, MSRC)               April 2018 
o Advanced Imaging Mass Spectrometry (AIMS) Laboratory Course- “Surface Sampling Technologies” 
o Taught laboratory skills to 30 scientists (technicians, graduate students, postdocs, principal investigators) 
Invited Panelist (American Society for Mass Spectrometry Annual Conference 2017 [ASMS])               June 2017 
o GSC “Graduate Student Panel: Experiences and Advice” Event 
o Q&A for ~20 undergraduate students regarding professional and academic scientific work experiences 
Workshop Assistant (Vanderbilt University, Department of Biochemistry, MSRC)               April 2017 
o Advanced Imaging Mass Spectrometry (AIMS) Laboratory Course- “Liquid Extraction Surface Analysis” 
o Taught laboratory skills to 27 scientists (technicians, graduate students, postdocs, principal investigators) 
Workshop Assistant (Vanderbilt University, Department of Biochemistry, MSRC)               April 2016 
o AIMS Laboratory Course- “FTICR Instrumentation and Applications” 
o Taught laboratory skills to 26 scientists (technicians, graduate students, postdocs, principal investigators) 
Lecture Series (Vanderbilt University, Department of Biochemistry, MSRC)                            Fall 2015 - present 
o Lecturer: “Ion Optics and Ion Transmission”, “Ultraviolet Photodissociation and Ion Spectroscopy” 
Teaching Assistant (University of North Carolina at Charlotte, Department of Chemistry)            Spring 2015 
o Physical Chemistry: Thermodynamics  
o Assisted in course instruction for 28 undergraduate students 
o Course instruction included exam administration, grading assignments (quizzes, labs, homework), leading review  
sessions, and holding office review hours for students 
Laboratory Assistant (University of North Carolina at Charlotte, Department of Chemistry)                Fall 2014 
o Quantitative Analysis 
o Assisted in the execution of the laboratory course instruction with the professor for 30 undergraduate students 
o Managed laboratory assignments such as assisting and demonstrating various experiments, and ensuring  
experiments were prepared for each course. 
Teaching Assistant (University of North Carolina at Charlotte, Department of Chemistry                Fall 2014 
o Physical Chemistry: Quantum Mechanics 
o Assisted in course instruction for 28 undergraduate students 
o Course instruction included exam administration, grading assignments (quizzes, labs, homework), leading review sessions,         
and holding office review hours for students 
 
 
 
 
